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Zusammenfassung 
Nur Keimzellen können die genetische Information von einer Generation zur nächsten 
übertragen. Trotz großen Interesses sind aber die grundsätzlichen Abläufe, die der 
Keimzellentwicklung unterliegen, bis heute kaum verstanden. Ein Grund dafür ist 
sicherlich, dass uns nur ungenügende Mengen an Zellmaterial für experimentelle 
Untersuchungen zur Verfügung stehen. Eine Lösung dafür könnte die Etablierung von 
in vitro Differenzierungsmethoden zur Gewinnung Primordialer Keimzellen (PGC) 
aus pluripotenten Stammzellen der Maus und des Menschen sein. Wenn die 
Differenzierungen in der Kulturschale die Keimzellentwicklung in vivo 
rekapitulierten, hätte man eines wichtigen Verfahren, um die Keimzellentwicklung 
besser zu verstehen.  
 
Ziel der hier vorgelegten Dissertation war es, ein effizientes und reproduzierbares 
Differenzierungsprotokoll zur Generierung Primordialer Keimzellen aus pluripotenten, 
humanen Stammzellen zu etablieren und molekulare Mechanismen, die den Ablauf 
bestimmen, aufzuklären. Da ein Großteil unseres Wissens über die 
Keimzellentwicklung mit Mäusen entwickelt wurde, enthält diese Dissertation auch 
Studien zweier Keimzellprojekte die modellhaft mit Mäusen durchgeführt wurden: 
"Differenzierung von primordialen Keimzellen aus normalen Epiblast Stammzellen 
(EpiSC) und stabilisierten Epiblast Stammzellen ( Δ PE-Oct4-GFP+)" und 
"Ultrastrukturelle Charakterisierung von Oozyten und Granulosazellen aus 
embryonalen Stammzellen". 
 
In meiner Arbeit habe ich ein definiertes und effizientes Differenzierungssystem zur 
Induktion prämigratorischer PGC aus humanen ESC und iPSC entwickelt. Durch eine 
stufenweise Differenzierung konnte ich eine OCT4+/T+/BLIMP1+ PGC-
Vorläuferpopulation ableiten. Diese Vorläuferpopulation wurden dann in STELLA-
positive (auch bekannt als DPPA3) Zellen differenziert, die wesentliche Merkmale 
von PGCs der Maus besaßen, u.a. die Expression von Schlüsselgenen und eine 
globale epigenetische Reprogrammierung. Obwohl in diesen Zellen PRDM14 nur 
schwach exprimiert wird, werden ähnlich wie in der Maus Pluripotenz/PGC Gene 
aktiviert und die neurale Induktion sowie die de novo DNA Methylierung unterdrückt. 
Diese Studie zeigt, dass die PGC Spezifizierung im Menschen und in der Maus recht 
!#"""!
ähnlich aber nicht identisch ist, , was auf bislang unbekannte Regulationsabläufe 
hinweist. 
 
Mittels Zellen der Maus haben wir PGCs aus EpiSCs und ΔPE-Oct4-GFP+ EpiSCs 
induziert. Wir konnten PGC-ähnliche Zellen aus EpiSC generieren, die 
charakteristische, prä-meiotische Gene wie Stella, Dazl und Vasa stark induzierten 
und zudem SYCP3 Protein im Kern aufwiesen. Allerdings war die Induktion von 
PGC-ähnlichen Zellen ausgesprochen variabel, was meines Erachtens an 
Unterschieden der verwendeten konditionierten Medienchargen liegt. Um PGCs 
reproduzierbar von EpiSC abzuleiten, müssen aus meiner Sicht chemisch definierte 
Differenzierungsbedingungen entwickelt werden.  
 
Im zweiten Mausprojekt wurden ESC-abgeleitete Oozyten und Granulosazellen via 
Elektronenmikroskopie charakterisiert. Wir konnten außergewöhnliche 
ultrastrukturelle Ähnlichkeiten zwischen den in vitro-generierten Oozyten und 
Granulosazellen und den entsprechenden Komponenten natürlicher Keimbahnfollikel 
der Maus aufzeigen, wie z.B. die charakteristische Struktur der Organellen in 
Granulosa Zellen, die Formation von Transzonalen Projektionen (TZPs) und die 
Bildung von kortikalem Granulat im Kortex der Eizelle. Unsere Studie belegt, dass in 
vitro Differenzierungssysteme die essentiellen Komponenten, welche für die 
Oozytenentwicklung erforderlich sind, generieren können: Oozyten, eine ECM-
basierte Interphase und Granulosazellen. 
 
Zusammengefasst zeigen unsere Daten, dass ESC-abgeleitete humane PGCs und in 
vitro generierte Oozyten der Maus ihren natürlichen Gegenstücken stark ähneln. 
Zusätzlich weisen unsere Studien auf bisher unbekannte Mechanismen während der 
humanen Keimzellspezifikation hin. Weitere Untersuchungen werden zeigen wie 
vorteilhaft solche in vitro Differenzierungsmodelle als alternative Ansätze für 
Untersuchungen in der reproduktiven Entwicklung tatsächlich sind. 
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Abstract 
Germ cells are the only cell type that can transmit genetic information from one 
generation to the next. The key mechanisms underlying germ cell development 
remain poorly understood due to the insufficient availability of cell materials for 
experimental investigations. The establishment of in vitro PGC differentiation models 
from mouse and human pluripotent stem cells that recapitulate the development of in 
vivo germ cells provides an alternative approach for studying reproductive 
development. 
 
The aim of this dissertation was to establish an efficient and reproducible 
differentiation protocol of PGCs from human pluripotent stem cells, and the 
investigation of molecular mechanisms involved in their development. Since most of 
our common knowledge of germ cell development is based on the mouse system, this 
dissertation also contains work performed on two mouse germ cell differentiation 
projects, namely "Differentiations of PGC-like cells from normal EpiSCs and so 
called stabilized EpiSCs” and "Ultrastructural characterization of mouse ESC-derived 
oocytes and granulosa cells". 
 
I developed a defined and efficient differentiation system for the induction of pre-
migratory PGC-like cells from human ESCs and iPSCs. By step-wise differentiation, 
we generated an OCT4+/T+/BLIMP1+ PGC-precursor-like cell population that 
transitioned into STELLA (also known as DPPA3) expressing PGC-like cells that 
exhibited a similar key gene expression as mouse PGCs as well as global epigenetic 
reprogramming. Interestingly, even though these PGC-like cells expressed PRDM14 
only at very low levels, they underwent activation of pluripotency/PGC genes, 
suppression of neural induction and suppression of de novo DNA methylation, events 
that are regulated by Prdm14 during mouse PGC specification. This study 
demonstrates that human PGC commitment shares many key features with mouse 
PGC specification, but harbors unique and so far unknown mechanisms that point to a 
novel human transcriptional regulation.  
 
In another project, we attempted to induce PGCs from mouse EpiSCs and from mouse 
stabilized EpiSCs (!PE-Oct4-GFP+). We generated PGC-like cells from normal 
!$!
EpiSCs that exhibited upregulation of PGC genes, such as Stella, Dazl and Vasa, and 
nuclear expression of SYCP3, which are characteristics of pre-meiotic PGCs. 
Unfortunately, we could not achieve reproducible induction of PGCs from these cells, 
nor from !PE-Oct4-GFP+ EpiSCs, most probably due to batch-dependent differences 
in the condition medium we used during the course of the experiments. Our results 
strongly suggest the requirement of chemically defined media compositions for the 
reproducible induction of PGCs from EpiSCs in vitro.  
 
In the second mouse project, characteristics of mouse ESC-derived oocytes and 
granulosa cells were determined at the electron microscopy level. We found a striking 
ultrastructural similarity of in vitro-generated oocytes and granulosa cells to cells 
comprising the natural follicle, such as the characteristic appearance of organelles in 
granulosa cells, the formation of transzonal projections (TZPs) and the formation of 
cortical granules in the oocyte cortex. This study demonstrated that in vitro 
differentiation systems can generate the essential components required for oocyte 
development: oocytes, an ECM-based interface, and granulosa-like cells. 
 
In summary, our data demonstrate that ESC-derived human PGC and in vitro 
generated mouse oocytes exhibit similar characteristics to their natural counterparts. 
In addition, our study proposes novel molecular mechanisms during human PGC 
specification. Those results clearly demonstrate the benefit of in vitro germ cell 
differentiation models as alternative approach for studying reproductive development.  
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1. Introduction 
The aim of this dissertation was to investigate the molecular mechanisms of mouse 
and human germ cell development. In order to achieve this, we aimed at the 
establishment and utilization of in vitro differentiation of mouse or human PGCs from 
PSCs. Prior to presenting the obtained results, it is important to provide an overview 
of our current understanding of germ cell development per se and the development of 
in vitro differentiation systems in both mouse and human. The introduction will lay a 
solid foundation and place the presented data in the relevant context of the current 
knowledge. 
 
1.1. Germ cells 
Germ cells are the only cell type in the body that can carry genetic information onto 
the next generation, whereas the somatic cell lineages give rise to the soma, or body 
(Weismann, 1893). The development of germ cells from PGCs to mature gametes 
(sperm and oocyte) involves a series of complicated biological processes that occur 
over a given period of time, which can be subdivided into several steps: specification, 
migration, epigenetic reprogramming, sex differentiation and meiosis, and oogenesis 
or spermatogenesis. A complex temporal and spatial activation of genetic programs 
rigorously regulates the sequence of developmental events. Despite recognizing the 
importance of germ cells, the scientific community has not yet elucidated the 
molecular mechanisms underlying the individual steps of germ cell development—
these remain poorly understood, owing in part to the lack of sufficient cell materials 
for conclusive studies.  
 
Current understanding of the mechanisms underlying germ cell determination and 
differentiation is based largely on studies performed in mice. As the series of 
sequential events during germ cell development is conserved among mammalian 
species, this section mainly provides an overview of germ cell development in the 
mouse, followed by a fragmentary but essential knowledge of human germ cell 
development. Despite large numbers of essential sets of genes involved in 
gametogenesis, only a small subset of genes that are known to play pivotal roles 
during germ cell development will be outlined in this introduction.  
%&'()*+,'")&!
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1.1.1. Primordial gem cell specification 
MOUSE The germ cell lineage is not allocated in the embryo proper of mammals 
before implantation—unlike the case of lower-order eukaryotes, as early epiblast cells 
injected into blastocysts have an equipotent ability to enter the mouse germline 
(Gardner & Rossant, 1979; Rossant et al, 1978). Cells within the proximal epiblast 
begin their commitment to become PGCs at the onset of gastrulation, between 5.5 to 6 
dpc (Yoshimizu et al, 2001), with the entire epiblast retaining this germline plasticity 
as late as 7 dpc (Tam & Zhou, 1996) in response to paracrine signaling from the 
extra-embryonic ectoderm (ExE) and visceral endoderm (VE) (Ginsburg et al, 1990). 
BMP2, BMP4, and BMP8, members of the bone morphogenetic protein family, 
induce Smad1, Smad5, and Smad8 signaling in the Oct4, TNAP, fragilis triple-
positive founding cell population of the proximal epiblast, which subsequently 
comprises approximately 45 committed PGCs by 7.25 dpc (Fujiwara et al, 2001; 
Lawson et al, 1999; Ying et al, 2000; Ying & Zhao, 2001). Studies on this process at 
a single cell level have revealed that PGCs initially share similar properties with their 
somatic mesodermal neighbors, as indicated by the expression of T and Hoxb1. 
Subsequent repression of the somatic program and activation of the PGC program 
enable the emergence of PGCs with TNAP activity and Stella expression (Figure 1) 
(Kurimoto et al, 2008; Saitou et al, 2002; Yabuta et al, 2006). Importantly, Sox2 
appeared to be repressed at the initiation of specification and re-acquired upon 
establishment of committed PGCs, while Nanog is constantly expressed. Blimp1 (also 
known as Prdm1) and Prdm14 are key factors for mouse PGC specification. They 
play an essential role in the repression of the somatic mesodermal program, activation 
of the PGC program, and global epigenetic reprogramming (Saitou et al, 2002; Seki et 
al, 2007; Yabuta et al, 2006). Interestingly, a recent study has demonstrated that 
ectopic expression of Blimp1 and Prdm14 together with Tfap2c is sufficient to induce 
mouse PGC-like cells from Epiblast-like cells in vitro, supporting the idea that these 
two factors play a dominant role in mouse PGC specification (Nakaki et al, 2013). 
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Figure 1 Scheme of gene expression dynamics during mouse PGC specification. 
HUMAN The founders of germ cells are recognized in the embryo at the wall of the 
yolk sac at the angle with the allantois at around the end of the third week (Felix, 
1911; Fuss, 1911; Fuss, 1912). These cells are distinguishable by their large size, 
spherical shape, the presence of abundant glycogen granules in the cytoplasm and 
their TNAP activity (Mc et al, 1953). BMP4 signaling seems to play a role in human 
PGC specification, as in vitro differentiation of PGCs from human ESCs has been 
shown to be enhanced by BMP4 (Kee et al, 2006). Those observations indicated that 
human germ cells have similar properties to mouse germ cells. However, there are 
only a few reports in the literature that detail gene expression dynamics during human 
PGC specification, which occurs before the 4th week of embryonic development. 
Nevertheless, immunochemical studies of carcinomas, germ cell tumors, and early-
mid stage germ cells have revealed that human germ cells exhibit a similar expression 
pattern of a number of key genes. BLIMP1 was observed to be expressed in germ 
cells within 12 week gonads and 19 week testis (Eckert et al, 2008). TFAP2C was 
also found in germ cells from both testis and ovary from the 10th to the 22nd week. 
The expression of these genes at late stage implies their conserved roles during human 
PGC specification. In contrast, the expression pattern of PRDM14 and STELLA in 
human germ cells has not been investigated so far. Among the genes associated with 
pluripotency, OCT4 and NANOG are expressed in human germ cells (Kerr et al, 
2008a; Kerr et al, 2008b). OCT4 expression was observed in 5.5 week and 7 week 
gonads in female and male, respectively. These OCT4+ PGCs co-expressed NANOG. 
On the other hand, SOX2 has been shown to be absent in human germ cells (de Jong 
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et al, 2008; Perrett et al, 2008), but cooperates with OCT4 and NANOG to regulate 
pluriotency in both mouse and human ESCs (Boyer et al, 2005; Fong et al, 2008; 
Wang et al, 2006). It is expressed in cells of the inner cell mass (ICM) and PGCs in 
mouse (Avilion et al, 2003), as well as in the human ICM (Cauffman et al, 2009). 
Those studies support the notion that the pluripotency network in human germ cells is 
differentially regulated compared to other cell types. Interestingly, a study in sheep 
revealed that Sox2 was apparently downregulated during PGC development, despite 
the maintenance of Oct4 and Nanog (Ledda et al, 2010), which further implies the 
difference of Sox2/SOX2 expression in different species. 
 
1.1.2. Germ cell migration  
MOUSE After their commitment, PGCs migrate through amoeboid-like movements 
toward the dorsal region of the fetus and reach the genital ridges at around 10.5 dpc. 
Genes that are expressed in the germ cells and in the soma ensure not only PGC 
survival, but also proper gonad formation. Signaling cascades emanating from 
gonadal somatic cells as well as cell-to-cell interactions ensure PGC proliferation, 
survival, and colonization of the gonads. For example, expression of !1 integrin and 
E-cadherin (Anderson et al, 1999; Bendel-Stenzel et al, 2000) in PGCs facilitates 
their interaction with the extracellular matrix (ECM) and cell-to-cell adhesion via 
cellular processes. Receptor-ligand interactions, such as c-Kit signaling by KITL (also 
known as SCF) or chemokine responsiveness of PGCs to SDF1 signaling from the 
genital ridge, are crucial (Hutt et al, 2006; Molyneaux et al, 2003) for germ cell 
development and subsequent maturation of PGCs into gametes. Upon reaching the 
genital ridges, PGCs upregulate Dazl (Cooke et al, 1996) and Vasa (also known as 
Ddx4) (Noce et al, 2001; Toyooka et al, 2000). Interestingly, these genes are 
primarily regulated by promoter DNA methylation (Maatouk et al, 2006), suggesting 
that their expression possibly reflects the global epigenetic reprogramming during 
migration (described later). Indeed, recent studies suggest that many genes implicated 
in later stages of germ-cell development, such as gametogenesis and meiosis, are 
regulated by promoter DNA methylation (Borgel et al, 2010; Guibert et al, 2012). 
 
HUMAN During the fourth week, when the embryonic disc undergoes a process of 
folding, PGCs are passively incorporated into the embryo together with the yolk sac 
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wall. The gonadal ridges are visible as a distinct structure at the beginning of the fifth 
week. At this time, PGCs start migrating and reach the gonadal ridges at week 6 
(Falin, 1969; Fujimoto et al, 1977; Mc et al, 1953; Mollgard et al, 2010). Human 
PGCs show several features of motile cells and are able to move actively both on 
cellular and ECM substrates (Freeman, 2003; Kuwana & Fujimoto, 1983). Similar to 
mice, KITLG (human homolog of mouse KITL) and SDF1 are also implicated in 
directing the migration of human PGCs, as the KITLG receptor c-KIT is expressed in 
human PGCs (Hoyer et al, 2005) and putative PGCs derived from human ESCs 
express the SDF1 receptor CXCR4 (Bucay et al, 2009). DAZL and VASA are also 
expressed in human gonadal germ cells from week 6 on (Anderson et al, 2007; 
Castrillon et al, 2000; Gkountela et al, 2013). Interestingly, the CpG islands of Dazl 
and Vasa in the mouse appear to be conserved in humans, and they remain 
hypomethylated in sperm but not other somatic tissues (Chai et al, 1997; Sugimoto et 
al, 2009). Whether regulation of germline-specific genes by promoter methylation is a 
general feature in humans is still unclear.  
 
1.1.3. Epigenetic reprogramming 
MOUSE The full commitment of cells toward the germ cell lineage is contingent 
upon the fine-tuned molecular mechanisms regulating the maintenance of genomic 
imprinting. DNA methylation, a key mechanism of this stage of development, 
regulates the imprinted allele-specific gene expression. Once established, the 
methylation status of the DNA is typically stable through generations. However, the 
dynamic changes in the DNA methylation of germ cells take place at specific time 
points in germ cell development—namely in fertilized embryos and in PGCs. There 
are two phases of DNA demethylation during PGC development. The first phase 
occurs immediately during migration at around 8.0–8.5 dpc and involves global 
depletion of cytosine methylation and histone modification. There is a marked 
reduction in H3K9me2, starting at around 7.5 dpc until and continuing until 8.75 dpc, 
followed by an increase in H3K27me3 between 8.25 and 9.5 dpc (Seki et al, 2007). 
There is also a decrease in Dnmt3a and 3b transcripts and protein at 7.25 and 8 dpc, 
respectively (Seki et al, 2005; Yabuta et al, 2006). This is accompanied by a reported 
decrease in 5-methylcytosine (5mC) at 8 dpc (Seki et al, 2005). Prmt5, an arginine-
specific histone methyltransferase that mediates H2AR3me2s and/or H4R3me2s, is 
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enriched in PGCs from 8.5 dpc on, and the H2A/H4R3me2s shows higher 
accumulation in PGCs than somatic cells at 10.5 dpc (Ancelin et al, 2006). The 
second phase takes place at 11 dpc and involves locus-specific demethylation at 
DMRs in a Tet-dependent manner (Hajkova et al, 2008; Hajkova et al, 2002; Hajkova 
et al, 2010; Vincent et al, 2013). This reprogramming results in demethylation of 
many repetitive elements but critically includes the erasure of imprints, allowing the 
establishment of sex-specific imprints during gametogenesis.  
 
HUMAN The early stage of reprogramming has not been well studied in humans at 
this early stage of development. Nevertheless, some studies have revealed similarities 
to mice after colonization of the gonad (Gkountela et al, 2013; Wermann et al, 2010). 
The level of 5mC in human PGCs seemed to be reduced during development, as 5mC 
was undetectable in PGCs from the 7th-17th week in testes and the 6th-19th week in 
ovaries, while it was detected in surrounding somatic cells. H3K27me3 was enriched 
in the nuclei of PGCs in testes between the 7th to 10.5th week. However, at 11 weeks, 
H3K27me3 was undetectable in most of the OCT4+ PGCs. Interestingly, at 17 weeks 
in testes, H3K27me3 was again observed in the nuclei of 38% OCT4A+ PGCs. In 
ovaries, H3K27me3 was absent in 50–60% of PGCs at 6–8.5 weeks, after which all 
PGCs were negative for H3K27me3. Furthermore, H2A.Z was enriched in the nuclei 
of PGCs at 7–9 weeks in the testis and 7.5 weeks in the ovary. The high level of 
H2A.Z, a variant of histone H2A, was observed at 16–20 weeks in testis. Another 
study also reported the low levels of H3K9me2, H3K27me3, and H3K9me3, but  high 
levels of H3K9ac and H2A.Z in male germ cells at around week 16–20 (Almstrup et 
al, 2010). PRMT5 was expressed in BLIMP1+ germ cells (Eckert et al, 2008). These 
data demonstrate the change of histone modification in human PGCs. Demethylation 
of imprinted genes seems to start between week 9 and 16. The paternally methylated 
H19 and MEG3 DMRs were methylated between the 9th-20th week in male c-KIT+ 
PGCs, whereas maternally methylated DMRs in the testis exhibited a sharp reduction 
of methylation between the 16th and 17th week. In the ovary, a significant reduction 
of CpG methylation was observed by 16.5 weeks at all loci (H19, MEG3, PEG3 and 
KCNQ1) (Gkountela et al, 2013).  
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1.1.4. Sex differentiation and Meiosis 
MOUSE After colonizing the genital ridges, the PGCs (now called gonia) are 
exposed to retinoic acid (RA) and interact with sex-specific somatic Sertoli or 
granulosa cells. The signals from these gonadal somatic cells precipitate the onset of 
sexual differentiation of the gonia at around 13.5 dpc (Koubova et al, 2006). 
Consequently, in the male genital ridge, PGCs undergo mitotic arrest and become 
irreversibly committed to a spermatogenic cell fate by 14.5 dpc (Ohta et al, 2004). 
These spermatogonia resume cell proliferation at around 10 dpp to continue 
spermatogenesis. In the female gonads, gonia reside in clusters, the so-called germ 
cell cysts, enter meiosis at around 13.5 dpc, and transiently arrest at the diplotene 
stage of meiosis 1 as oocytes by 18.5 dpc. Meiosis is a unique type of cell division 
that generates gametes with a haploid parental chromosome set. Specialized 
interactions between chromosomes and modification of the cell cycle machinery 
facilitate chromosome segregation—a precisely timed process involving complex 
pathways. Errors in meiosis are the leading cause of birth defects and infertility, and 
unraveling the mechanisms involved in the meiotic process represents one of the 
biggest challenges in developmental biology. In female mice, RA induces the 
expression of pre-meiosis gene Stra8 and oocytes initiate meiosis in the fetal ovary 
between 13.5 and 16.5 dpc and arrest in the diplotene stage of the meiotic prophase 1 
by 18.5 dpc. At the onset of meiosis, germ cells express meiosis-specific proteins, 
such as SYCP1, SYCP2, and SYCP3, and form "H2AX, which play a role in axial 
core compaction, synapsis, and recombination. Downregulation of Sycp1 in occytes 
coincides with the arrest of oocytes in the diplotene stage of prophase 1 and is thought 
to signal somatic cells to begin organizing the primordial follicles (Paredes et al, 
2005). Oocytes resume meiosis 1 by entering into metaphase 1 during folliculogenesis 
a few weeks after birth to arrest again in the second meiotic division prior to ovulation.  
 
HUMAN Whether in human during sex differentiation is also induced by RA has not 
yet been determined. However, the expression of RA synthesizing enzymes 
(RALDH1, 2 and 3), along with retinoic acid receptor (RAR) expression was detected 
in human fetal ovaries (Childs et al, 2011; Le Bouffant et al, 2010), indicating that the 
induction of meiosis by RA is not limited to mice. In a human fetal organ culture 
system, RALDH1 was expressed at highest levels during meiosis initiation (11th–12th 
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week) and its inhibition by citral reduced numbers of meiotic germ cells. Conversely, 
addition of exogenous RA to this system increased the numbers of meiotic germ cells 
compared to controls (Childs et al, 2011). Importantly, STRA8 expression is reported 
to start from the 12th week on in the gonad (Houmard et al, 2009) and SYCP3 
expression was observed in human gonadal germ cells at least in the ovary at week 16 
(Liu et al, 2007), indicative of meiotic progression.  
 
1.1.5. Folliculogenesis and oocyte maturation 
MOUSE Shortly after birth, germ cell cysts degenerate and about one third of the 
oocytes become enclosed by granulosa cells and form primordial follicles, while the 
remaining oocytes undergo programmed cell death (Pepling & Spradling, 2001). 
Upon activation of the primordial follicle, the complex process of folliculogenesis 
ensues, with a bidirectional communication between the oocyte and the companion 
granulosa cells directing follicle development (Eppig, 2001; Eppig et al, 2002). The 
oocyte and surrounding granulosa cells are structurally and functionally associated via 
specialized cytoplasmic processes called transzonal projections (TZPs) and zona 
pellucida (ZP), representing a highly dynamic interaction regulating folliculogenesis 
in vivo and thereby ensuring appropriate oocyte maturation and ovulation (Albertini 
et al, 2001). Primordial follicles transition to become primary follicles when the 
granulosa cells surrounding the oocyte turn into cuboidal granulosa cells. SCF, LIF 
and bFGF secreted by the somatic compartment, and c-kit, Figla, Sohlh1, Sohlh2, 
Nobox and Lhx8 expressed by the oocyte promote this transition and rapid growth of 
the oocyte. During the secondary follicle stage, proliferation of granulosa and theca 
cells is mediated by expression of Gdf9 and Bmp15 in the oocyte (Jagarlamudi et al, 
2010). Subsequently, in response to follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH), follicles form an antrum, initiating the process of 
steroidogenesis. Once the oocyte reaches maturity within the antral follicle, ovulation 
proceeds and meiosis resumes.  
 
HUMAN A detailed expression pattern of genes during development has not been 
reported yet. Nevertheless, the expression of a variety of genes expressed in mouse 
oocytes has also been observed in human oocytes. FIGLA expression was observed in 
ovaries between week 14 to at least week 19 (Bayne et al, 2004) and in all follicle 
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stages of the adult ovary (Huntriss et al, 2006). NOBOX is expressed in all follicle 
stages of the adult ovary (Huntriss et al, 2006) and LHX8, GDF9, ZP1, ZP2 and ZP3 
are expressed in oocytes (Moriguchi et al, 2012). These studies support the notion that 
oocyte-related genes are well conserved between humans and mice. Importantly, 
mutations of LHX8, FIGLA and BMP15 have been detected in premature ovarian 
failure patients, suggesting that these genes are likely key mediators of fertility in 
humans (Suzumori et al, 2007).  
 
 
Table 1 Comparison of gene expression profiles of PGCs between different mammals. 
 
  Mouse Human 
Early PGC genes Blimp1 + + 
Prdm14 + ND 
Tfap2c + + 
Stella + ND 
Pluripotency genes Oct4 + + 
Nanog + + 
Sox2 + - 
SSEA-1 + + 
c-KIT + + 
Late PGC genes Dazl + + 
Vasa + + 
Meiosis genes Stra8 + + 
Sycp1-3 + + 
Oocyte genes Figla + + 
Nobox + + 
Lhx8 + + 
Gdf9 + + 
Zp1-3 + + 
 
 
1.2. Germ cell differentiation from mouse and human embryonic stem cells  
ESCs are cells derived from the ICM of preimplantation blastocysts (Evans & 
Kaufman, 1981; Martin, 1981; Thomson et al, 1998). These cells have the ability to 
self-renew indefinitely while maintaining the feature of pluripotency, defined as the 
potential to differentiate into cell types of all three germ layers (ectoderm, endoderm, 
and mesoderm) and germ cells. The establishment of mouse and human ESCs brought 
great excitement not only to the scientific community, but also to the clinical setting, 
raising high expectations on the potential use of these cells to broaden our 
understanding of the mechanisms involved in development and disease. However, the 
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controversy surrounding the derivation of ESCs from “human embryos” has limited 
the number of cell lines that were derived.  
 
A breakthrough from 2006 in the field of stem cell research has the potential to 
overcome this limitation. Mouse somatic cells were reprogrammed into so-called 
iPSCs by the ectopic co-expression of the four transcription factors Oct4, Sox2, Klf4, 
and c-Myc (Takahashi & Yamanaka, 2006). Mouse iPSCs are able to generate 
functional germ cells (Okita et al, 2007; Wernig et al, 2007) and, most importantly, 
are competent to form a full embryo by tetraploid embryo complementation (Kang et 
al, 2009; Zhao et al, 2009). Only one year after the first mouse iPSCs report, 
reprogramming of human cells was achieved by the same combination of 
transcription factors (OCT4, SOX2, KLF4 and C-MYC) and by a different 
combination of factors (OCT4, SOX2, LIN28 and NANOG) (Takahashi et al, 2007; Yu 
et al, 2007). Although further investigations are required to unravel how the 
reprogramming machinery works, this new technique enables the derivation of 
patient-specific iPSCs for disease modeling, drug screening, and investigations into 
the causative mechanisms underlying disease. 
 
Over the past few years, several studies reported the differentiation of PGCs in vitro 
from pluripotent stem cells, including iPSCs, from a variety of organisms. Amazingly, 
some reports even demonstrated further maturation of these germ cells into 
presumptive gametes, suggesting that in vitro differentiation models are powerful 
tools for the studying gametogenesis. Prior to examining in vitro germ cell 
development and gametogenesis, a brief review of mouse germline development will 
be provided. This will be followed by an overview of the advances in germ cell 
differentiation using mouse and human stem cells to date, with a focus on the 
generation of oocytes. The chapter will end with a presentation of the challenges 
encountered in the successful generation of mature gametes. 
 
1.2.1. In vitro differentiation of mouse germ cells 
1.2.1.1. In vitro differentiation of post-migratory PGCs 
Between 2003 and 2004, three independent groups showed that mouse ESCs are 
capable of spontaneously differentiating into both male and female germ cells 
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(Geijsen et al, 2004; Hubner et al, 2003; Toyooka et al, 2003). During the following 
10 years, this research field experienced a steady increase of attention, and gradually 
shifted from spontaneous differentiation strategies to inductive strategies.  
 
In 2003, Hübner et al. reported the generation of PGCs in vitro from XY-mouse ESCs 
that followed the oogenesis pathway upon extended culture (Hubner et al, 2003). The 
authors differentiated ESCs as a feeder-free monolayer in the absence of LIF and 
observed Oct4+/Vasa+ post-migratory PGC-like cells after about 8 days of culture. 
Aggregates of Oct4-/Vasa+ cells were subsequently found to detach from the cell 
layer and produce large SYCP3 positive oocyte-like cells. After 30 days of culture, 
rare blastocyst-like structures were detected, indicative of parthenogenetic activation. 
However, the functionality of the presumptive oocytes was not shown. Shortly 
afterwards, Toyooka et al. published a study describing the differentiation of ESCs 
into male germ cells in vitro (Toyooka et al, 2003). In this study, mouse ESCs were 
co-aggregated with BMP4-producing transgenic cells to form EBs and, interestingly, 
Vasa+ post-migratory PGC-like cells were detected within 1 day. These Vasa+ cells 
developed into sperm-like cells upon transplantation into mouse testis; however, 
fertilization was not reported. Similarly, Geijsen et al. described the in vitro 
generation of male haploid cells from spontaneously differentiating EBs under serum-
containing condition (Geijsen et al, 2004). Upon injection into oocytes by 
intracytoplasmic sperm injection (ICSI), the haploid cells developed into blastocysts, 
but offspring were not produced. Taken together, these initial reports clearly 
demonstrated the differentiation capacity of mouse ESCs into both male and female 
germ cells in culture, and spurred further efforts in the development of robust in vitro 
differentiation systems. 
 
It is worthwhile to mention that none of the early studies provided proof of 
competence and functionality of the ESC-derived germ cells. In this context, Novak et 
al. reported that ESC-derived germ cells exhibit abnormal progression through 
meiosis (Novak et al, 2006). Even though the PGC-like cells generated by those 
researchers exhibited SYCP3 protein expression, additional meiotic markers or 
homologous chromosome synapses specific for meiotic progression could not be 
detected, such as SYCP1 and SYCP2. This data imply that the majority of in vitro–
generated germ cells fail to undergo normal meiosis, which may explain their failure 
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to further differentiate into functional gametes. Nevertheless, a recent ultrastructural 
comparison between natural and ESC-derived oocytes and follicles by Psathaki et al. 
revealed that oocytes exhibited remarkable similarities, as did, interestingly, the in 
vitro produced granulosa-like cells. The aggregates analyzed in this study exhibited 
characteristics typical of natural follicles, i.e. one or multiple oocyte-like cells, an 
ECM-based interphase, and granulose-like cells exhibiting TZPs. This data suggest 
the presence of ongoing folliculogenesis with active interactions between germ cells 
and granulosa cells generated in vitro (Psathaki et al, 2011).  
 
In 2006, one report described the in vitro differentiation of fully-grown sperm, as 
ascertained by morphology and immunocytochemical staining for known sperm 
markers (Nayernia et al, 2006). According to this report, stable PGC-like cell lines 
were derived from mouse ESCs carrying a Stra8 reporter construct. Upon 
differentiation on inactivated MEFs and induction with RA, about 60% of the cells 
expressed Stra8, a RA-responsive gene involved in meiosis in the male mouse. The 
Stra8+ cell population was further cultivated under non-inducing conditions, giving 
rise to stabile cell lines with conserved Stra8 and PGC marker expression, including 
Oct4, Stella, and Vasa, indicative of spermatogonial stem cells (SSCs). After another 
course of RA treatment, Acrosin+ and haploid cells were detected in the culture, 
indicative of post-meiotic spermatids. However, analysis of these differentiated cells 
revealed incomplete epigenetic resetting. ESC-derived SSC-like cells gave rise to 
sperm after implantation into testis. After ICSI of the sperm into oocytes, live 
offspring were produced, but the progeny had obvious growth abnormalities and died 
within 5 months. This report has provided evidence for the potential derivation of 
male gametes in vitro, but the generation of healthy offspring still has to be 
demonstrated.  
 
1.2.1.2. Differentiation by co-culture with animal-origin somatic cells 
Other approaches for the in vitro generation of germ cells from ESCs utilize co-
cultures with gonadal somatic cells or cultures in conditioned medium. Lacham-
Kaplan et al. reported the formation of ovary-like structures containing oocyte-like 
cells from differentiating EBs in testis-conditioned medium that were collected from 
testicular cell cultures of male newborn mice (Lacham-Kaplan et al, 2006). After 2–5 
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days of differentiation, Oct4+/c-Kit+/Vasa+ PGC-like cells were observed, which 
further developed to 15–30 "m large oocyte-like cells within follicle-like structures. 
Even though expression of the oocyte markers Figla and Zp3 was shown, neither 
meiotic progression nor functionality had been confirmed. A similar report came from 
Qing et al., demonstrating that co-culturing EBs with granulosa cells from female 
newborn mice enhances female germ cell marker expression and oocyte-like cell 
formation (Qing et al, 2007). Different from other publications is the reported 
expression of Sycp1, Sycp2, and Sycp3 at the mRNA level in oocyte-like cells. 
However, SYCP3 proteins were detected in the cytoplasm in these cells, while SYCP 
proteins co-localize with DNA during meiosis in natural germ cells. Taken together, 
these data suggested that factors secreted by the somatic component of the gonads and 
the direct interaction of gonadal somatic cells with in vitro–generated germ cells 
appear to have a positive effect on the outcome of in vitro germ cell differentiation. 
However, these effects could not give rise to mature and functional gametes. 
Nevertheless, the identification of factors that enhance germ cell differentiation in 
these culture systems would greatly enhance our understanding of germ cell 
development both in vivo and in vitro.  
 
The lack of markers that can distinguish germ cells from ESCs likely constitutes the 
biggest limitation in the field of in vitro germ cell differentiation. PGCs and ESCs 
share most of the known markers of the germ cell lineage, hampering the ability to 
efficiently separate PGCs from ESCs or pluripotent cell populations. For example, 
SSEA-1 is not only commonly used for the identification of undifferentiated mouse 
ESCs, but it also serves as surface marker for the isolation of early PGCs from 
somatic cell populations. Nicholas et al. utilized #PE-Oct4-GFP ESCs and reported a 
combination of common markers can be used to distinguish early PGCs and late 
female germ cells, respectively, from differentiating ESCs, by considering the signal 
intensity during purification (Nicholas et al, 2009). An isolated Oct4+/SSEA1+ (high 
signal) population was enriched within differentiation cultures with early PGC 
markers, such as Oct4, Stella, Nanos3, and Vasa, while the corresponding 
Oct4+/SSEA1- population expressed the meiotic marker Stra8 and the oocyte-specific 
gene Gdf9, suggesting an oocyte identity. In addition, the expression of the meiotic 
markers was enhanced by addition of BMP4, RA, and CYP26 inhibitor—factors 
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known to stimulate meiosis. However, these in vitro ESC-derived oocyte-like cells 
showed blockage of meiotic progression, as indicated by only a partial SYCP3 
chromosomal alignment and the absence of SYCP1 elongation. To further assess the 
developmental capacity of the generated meiotic oocytes, co-aggregates with 
dissociated wild-type newborn ovarian tissues were transplanted into recipient female 
mice. The ESC-derived GFP+ oocytes were found to recruit somatic granulosa cells 
and develop up to the primary follicle stage. However, whether these follicles can 
progress further in development remains to be elucidated.  
 
1.2.1.3. In vitro differentiation of pre-migratory PGCs 
While the difficulty of meiotic progression in vitro impedes the robust establishment 
of post-migratory PGCs, one group successfully recapitulated PGC specification in 
vitro and generated pre-migratory PGCs. In 2009, Ohinata et al. established an ex vivo 
system for the generation of early PGCs from embryonic day (E)6.0 epiblast under 
serum-free defined culture conditions in the presence of BMP4, BMP8B, LIF, and 
SCF. After 6 days of culture, a small cell population expressing exclusively early 
PGC markers (including Blimp1, Stella, Oct4, and Vasa) had formed, representative 
of migratory PGCs. Furthermore, upon injection of PGC-like cells into neonatal 
mouse testis, they were found to develop into sperm, which subsequently produced 
live offspring after ICSI into oocytes (Ohinata et al, 2009). This study suggested that 
if epiblast-like cells can be obtained from other pluripotent cell types in vitro, the 
same protocol could be used to facilitate further differentiation into PGCs. Based on 
this report, Hayashi et al. introduced a 2-step differentiation protocol for ESCs—an 
approach that closely recapitulates germ cell commitment in vivo. ESCs were first 
converted into epiblast-like cell (EpiLCs) by induction with Activin A and bFGF, 
followed by differentiation into PGCs according to Ohinata et al. Global gene 
expression profiling of EpiLCs and PGC-like cells revealed a high similarity to their 
in vivo counterparts. Interestingly, EpiLCs were similar to E5.75 epiblast, but 
different from EpiSCs. Consistent with this observation, EpiSCs did not give rise to 
PGCs under the same differentiation regime. In vitro–derived PGCs also exhibited 
epigenetic properties and cellular dynamics similar those of in vivo PGCs. ESC-
derived PGCs were injected into neonatal mouse testis to produce sperm, which 
subsequently produced live offspring after ICSI into oocytes (Hayashi et al, 2011). 
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The authors later reported that these PGC-like cells are able to differentiate into 
oocyte upon transplantation into ovary (Hayashi et al, 2012). The authors reported 
that BLIMP1+/STELLA- PGCs were able to generate oocytes, demonstrating that 
PGC precursors have already acquired distinct PGC properties. The same group 
reported the induction of PGC-like cells by overexpression of three germ cell-related 
transcription factors (TFs), Blimp1, Prdm14 and Tfap2c (Nakaki et al, 2013). 
Overexpression of these TFs in EpiLCs successfully induced PGC-like cells under the 
same culture conditioned as described before but in the absence of cytokines. These 
TF-induced PGC-like cells exhibited similar global gene profiles and epigenetic 
profiles as wild type PGCs, and gave rise to functional sperm. Interestingly, even 
though the combination of the three factors induced PGC-like cells most efficiently, 
Prdm14 alone also induced the cells, indicating that Prdm14 plays a core function in 
PGC specification. This study revealed the core gene regulation of PGC specification 
in mouse. 
 
1.2.2. In vitro germ cell derivation from human pluripotent stem cells 
A great deal of our knowledge on PGC specification and development has been borne 
out of studies in the mouse embryo and over the last decade in particular in mouse 
ESC differentiation models. Due to the limited accessibility of cell materials, 
investigations into human gem cell development have only recently gained headway 
with the increasing use of human ESCs and iPSCs as an experimental model. Human 
pluripotent stem cells differ significantly from mouse pluripotent stem cells, and the 
same is thought true for germ cells. Direct extrapolation of data obtained from animal 
models to the human system is obviously not possible and several studies have 
already identified a variety of fundamental differences.  
 
1.2.2.1. The generation of post-migratory PGC-like cells 
One year after the first report of mouse in vitro germ cells, Clark et al. demonstrated 
that human ESCs are also capable of differentiating into PGCs (Clark et al, 2004). 
The authors compared the gene expression of human homologs of known mouse PGC 
markers in several human ESC lines, the ICM from human blastocysts, and human 
testis and observed that ESCs expressed early PGC markers such as STELLA and 
DAZL but not the late PGC markers such as VASA, SYCP1, SYCP3, BOULE, and 
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TEKT1. After the spontaneous differentiation of ESCs in EBs, the down-regulation of 
early PGC markers and up-regulation of later PGC markers confirmed the 
commitment of cells within the cultures to the germ cell lineage. In addition, a small 
number of VASA+ cells, representative of post-migratory PGCs, were detected at the 
border of the EBs. These encouraging findings spurred fervent interest toward the 
discovery of more efficient differentiation protocols. 
 
The same group later reported the inductive effect of BMP proteins on PGC marker 
expression during the differentiation of human ESCs into PGCs in vitro and addressed 
the conserved role of BMP proteins on PGC induction between human and mouse 
(Kee et al, 2006). BMP4 was found to induce VASA expression, whereas BMP7 and 
BMP8B did not show any individual effect, but rather enhanced the action of BMP4. 
Based on these data, the authors concluded that the combination of BMP4, BMP7, 
and BMP8B most strongly induces germ cell formation in vitro. This data indicated 
conserved molecular mechanisms on PGC specification between two species. 
 
Another report described the generation of human transgenic VASA-GFP ESC 
lines based on the observation that VASA is not expressed in ESCs (Kee et al, 2009). 
Those authors differentiated trangenic ESCs in medium supplemented with BMP4, 
BMP7, and BMP8b, based on their previous study (Kee et al, 2006). After 2 weeks, 
GFP+ cells were observed within cultures, which expressed also BLIMP1, STELLA, 
and DAZL and showed initiation of imprinting erasure of the H19 locus. However, the 
potential of meiotic progression and sexual bipotentiality of VASA+ cells remained 
unclear, as most of the analyzed cells did not express SYCP3 protein nor "H2AX, 
which are required for meiotic recombination and binding to double-stranded DNA 
breaks. The authors then investigated the role of DAZ, DAZL, and BOULE during 
the differentiation of human PGCs by utilizing the same differentiation protocol but 
omitting BMPs. Knockdown of the genes by short hairpin RNA (shRNA) led to a 
decrease in GFP+ cells, whereas overexpression of the genes led to progression of 
meiosis, indicated by a punctuate or elongated SYCP3 signal at higher frequency than 
that observed in wild type cells. These cells differentiated further into ACROSIN+, 
male haploid cells., The same group reported later that iPSCs could be differentiated 
into PGCs similarly to hESCs, suggesting that iPSCs might depict a promising 
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alternative to ESCs (Panula et al, 2011). Surprisingly, iPSC cultures contained more 
SYCP3-expressing cells than ESC lines under non-differentiating culture conditions, 
and one of the iPSC lines even contained a subpopulation of cells with elongated 
SYCP3 distribution. The authors suggested that iPSCs preferentially differentiate into 
the germ line, which might be linked to the enhanced expression of pluripotency 
markers during the reprogramming process. Medrano et al. utilized overexpression of 
VASA to enhance meiotic progression, and reported that even though VASA is not as 
effective as DAZL overexpression, VASA exhibits a synergistic effect with DAZL in 
ESCs and iPSCs (Medrano et al, 2011). These studies together suggest that DAZL 
and VASA play an important role in human germ cell development like in the mouse. 
 
In the context of meiotic competence of in vitro human germ cells, Chuang et al. 
reported the generation of SYCP3+ PGC-like cells without genetic modification. The 
authors differentiated OCT4-GFP transgenic ESCs in a serum-based medium 
containing BMP4 and WNT3A for up to 30 days and purified OCT4+ putative germ 
cells. Some of these OCT4+ cells expressed STELLA, DAZL and VASA at the 
protein level and importantly, 30% of the OCT4+ cells expressed SYCP3 in the nuclei. 
These PGC-like cells were then co-aggregated with dissociated newborn mouse 
ovaries and transplanted into the kidney capsule of NOD/SCID mice for 2 months. 
Even though some VASA+ or GDF9+ cells were detected in the reconstituted ovaries, 
further development into mature oocytes had not been shown. 
 
1.2.2.2. The generation of putative gametes 
There are some reports describing the generation of putative sperm-like cells without 
genetic manipulation. Bucay et al. reported the co-differentiation of in vitro PGCs and 
Sertoli cells from ESCs (Bucay et al, 2009). ESCs were first differentiated into VASA 
and AP double-positive PGC-like cells that revealed morphological characteristics of 
natural PGCs at the electron microscopy (EM) level. Upon further differentiation, 
these cultures showed increased expression of the late male GC markers VASA and 
ACROSIN and of the Sertoli cell markers MIS, FSHR, and SOX9, indicating the 
induction of late PGCs and Sertoli cell in the culture. In fact, these Sertoli-like cells 
exhibited morphological features characteristic of their in vivo counterparts, as 
analyzed by EM. However, although 45% of cells within the differentiation cultures 
expressed VASA and 35% expressed FSHR at the protein level, haploid cells were 
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not detected. Interestingly, this report mirrors the main findings of Psathaki et al., who 
performed an ultrastructural analysis of co-differentiated presumptive oocytes and 
granulosa cells generated from mouse ESCs.  
 
Eguizabal et al. reported the spontaneous generation of haploid cells from iPSCs 
(Eguizabal et al, 2011). iPSCs were cultured on MEF feeder cells without bFGF for 3 
weeks, followed by treatment with RA for additional 3 weeks. Early spermatogonia 
and spermatid marker-expressing cells were isolated and further cultivated in the 
presence of bFGF, LIF, Forskolin, and CYP26 inhibitor for another 3–4 weeks. By 
this time, VASA-expressing cells surrounded by somatic cells with marker expression 
typical of Sertoli and Leydig cells (VIMENTIN, NESTIN and 3!-HSD) were 
observed. Upon differentiation for an additional 4 weeks in the presence of factors 
supporting meiosis, a subpopulation of cells showed expression of the meiotic 
markers SYCP3 and "H2AX and the post-meiotic marker ACROSIN, indicating the 
formation of meiotic, i.e., haploid, cells. Analysis of the methylation status revealed a 
male-specific hypermethylation pattern of the H19 locus. Of importance is that the 
differentiation protocol did not work the same way for ESCs—as ESCs produced only 
VASA and SYCP3 double-positive and "H2AX-negative cells, similar to the report 
by Kee et al. (Kee et al, 2009). These findings and the report by Panula et al. (Panula 
et al, 2011) suggest that certain iPSC lines differentiated preferentially toward the 
germ line.  
 
1.2.2.3. Differentiation by co-culture with animal-origin somatic cells 
There are few studies employing co-cultures with animal-origin somatic cells that 
obtained putative matured gametes. West et al. reported the emergence of VASA+ 
PGC-like cells when ESCs were differentiated on MEF cells in the presence of bFGF 
without being passaged for 10 days (West et al, 2008). Amazingly, about 60% of the 
cells expressed OCT4 and VASA proteins. However, VASA localized to the 
nucleus—a phenomenon that needs to be explained and clarified, as it is typically 
expressed in the cytoplasm. The same group subsequently reported the establishment 
of a stable germ-like cell line (GLC) from those ESC-derived VASA+ cells (West et 
al, 2011). Extended culture of GLCs without passaging purportedly produced more 
than 70% of cells positive for the meiotic marker SYCP3 and the meiotic 
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recombination protein MLH1. Upon further differentiation, cells showed increased 
expression of the male germ cell marker ACROSIN, with more than 6% of cells being 
haploid. Interestingly, this group and Nayernia et al., who also generated haploid cells, 
reported similar data (Nayernia et al, 2006). For instance, both groups established 
ESC-derived stable germ-like cell lines that expressed late PGC markers (VASA and 
Stra8) and upon further differentiation produced SYCP3-expressing meiotic 
subpopulations. As the cell lines established by Nayernia et al. showed imprinting 
abnormality, it would be interesting to know the imprinting status of these GLCs.  
 
Park et al. reported that co-culturing of ESCs and iPSCs with human fetal gonadal 
stromal cells (hFGSCs) enhances the generation of PGCs (Park et al, 2009). When 
differentiated on hFGSCs in the absence of bFGF, both ESCs and iPSCs produced c-
KIT, SSEA-1, and VASA triple-positive cells that additionally co-expressed BLIMP1, 
STELLA, and DAZL by day 7. PGCs generated from ESCs initiated imprinting erasure, 
whereas iPSC-derived PGCs did not, indicating that iPSC-derived PGCs may have a 
compromised ability to undergo erasure of CpG methylation at imprinted genes. Of 
importance is that the induced differentiation of hFGSCs into PGCs was more 
efficient than that of placenta or liver stromal cells, suggesting that PGC induction is 
affected by not only the topology of the feeder cells, but also the specific cell type of 
the starting cell population. 
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Table 2. Overview of germ cell differentiation procedures cited in the introduction (modified Sugawa 
et al. 2013). mESC: mouse embryonic stem cell, miPSC: mouse induced pluripotent stem cell, hESC: 
human embryonic stem cell, hiPSC: human induced pluripotent stem cell, MN: monolayer, EB: 
embryoid body, MEF: mosue embryonic fibroblast, hFGSC: human fetal gonad stromal cell, R115866: 
CYP26 inhibitor, postPGC: post-migratory PGC, prePGC: pre-migratory PGC, PGC: primordial germ 
cell, 1: Upon transplantation into mouse, 2:Upon overexpression of germ cell-related genes(s) 
 
Reference Origin Approach / Factors 
supplemented 
Cells observed / 
Offspring 
Hübner et al. 2003 mESC ML / - postPGC, oocyte, 
blastcyst 
Toyooka et al. 2003 mESC EB / co-aggregate with TM4 
secreting BMP4 
postPGC, sperm 
Geijsen et al. 2004 mESC ML / - sperm, blastcyst (by 
ICSI)  
Lacham-Kaplan et al. 
2006 
mESC EB / mouse testis-conditioned 
medium 
oocyte 
Nayernia et al.2006 mESC ML / RA postPGC, sperm, 
offspring1 (abnormal) 
Novak et al. 2006 mESC ML / - oocyte 
Qing et al. 2007 mESC EB / co-culture with mouse 
granulosa cells 
oocyte 
Nicholas et al. 2009 mESC EB / BMP4, CYP26 inhibitor, 
SDF1, SCF, bFGF, n-acetyl-
cysteine, forskolin 
postPGC, oocyte 
Hayashi et al. 2011, 
2013 
mESC, 
miPSC 
ML+EB / Activin A, bFGF, 
BMP4, BMP8b, LIF, SCF, EGF 
prePGC, offspring1 
Vincent et al. 2011 mESC EB / - prePGC 
Psathaki et al. 2011 mESC ML+EB / ITS, EGF, SCF, BMP4, 
LIF, FSH 
oocyte 
Nakaki e al. 2013 mESC ML+EB / Activin A, bFGF postPGC2 (Blimp1, 
Prdm14, Tfap2c), 
offspring1 
Clark et al. 2004 hESC EB / - postPGC 
Kee et al.2006 hESC EB / BMP4, BMP7, BMP8b  
West et al.2008 hESC ML / co-culture with MEF, bFGF postPGC 
Tilgner et al. 2008 hESC ML / - postPGC 
Bucay et al. 2009 hESC ML / co-culture with MEF postPGC 
Park et al. 2009 hESC, 
hiPSC 
ML / co-culte with hFGSCs postPGC 
Kee et al. 2009 hESC ML / BMP4, BMP7, BMP8b postPGC, sperm2 (DAZ 
family) 
Panula et al. 2011 hESC, 
hiPSC 
ML / BMP4, BMP7, BMP8b postPGC, sperm2 (DAZ 
family) 
West et al. 2011 hESC ML / co-culture with MEF, bFGF postPGC, sperm 
Eguizabal et al. 2011 hESC, 
hiPSC 
ML / co-culture with MEF, RA, 
bFGF, LIF, Forskolin, R115866 
sperm 
Medrano et al. 2011 hESC, 
hiPSC 
ML / - postPGC, sperm2 
(VASA) 
Chuang et al.2012 hESC EB / BMP4, WNT3A postPGC 
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Figure 2 Chronology of mouse germ cell development and correlation of cited in vitro germ cell 
protocols (modified Sugawa et al. 2013). 
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2. Materials and methods 
2.1. Materials 
2.1.1. Reagents 
Name Manufacturer Catalogue number 
Accutase PAA L11-007 
Activin A, recombinant human/mouse/rat R&D systems 338-AC-010 
Anti-BLIMP1 antibody Cell Signaling 9115 
Anti-BRACHYURY (T) antibody Santa Cruz sc-17745 
Anti-OCT4A antibody  Santa Cruz sc-8628 
Anti-SSEA-1 (CD15) MicroBeads, human and mouse Miltenyi Biotec 130-094-530 
Anti-STELLA Antibody Millipore MAB4388 
Anti-5-Methylcytosine (Methyl-CpG) Antibody Aviva Amm99021 
α -MEM Sigma-Aldrich M4526 
BLIMP1 shRNA lentiviral knockdown constructs Thermo Fisher RHS4533-EG639 
BMP4, CF, recombinant Human R&D systems 314-BP-050/CF 
B27 supplement minus vitamin A Invitrogen 12587-010 
Chicken serum Invitrogen 16110-082 
CHIR99021 Biovision 1667-5 
DMEM/F-12 Invitrogen 21041-025 
DMEM high glucose PAA E15-009 
DMEM low glucose PAA E15-005 
DMSO Sigma-Aldrich D2650 
DNase I Sigma-Aldrich DN25 
Epidermal growth factor, recombinant human Invitrogen PHG0315 
EpiTect Bisulfite Kit QIAGEN 59104 
FastDigest Green Buffer Fermentas B72 
Fetal bovine serum Hyclone SH30070.03 
Fetal bovine serum gold PAA A15-151 
FGF-basic, recombinant human Peprotech 100-18B 
Fibronectin Sigma-Aldrich F2006 
Follicle stimulating hormone, recombinant human Sigma-Aldrich F4021 
Gelatin solution, 2% Sigma-Aldrich G1393 
GMEM Invitrogen 11710-035 
G418 sulfate Invitrogen 10131-035 
HindIII Fermentas FD0504 
HumanHT-12 v4 expression BeadChip kit Illumina BD-103-0204 
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Human Stem Cell Nucleofector Kit Lonza VPH-5012 
Illumina TotalPrep RNA Amplification Kit Ambion AMIL1791 
Insulin-Transferrin-Selenium-Sodium Invitrogen 51300-044 
Insulin-Transferrin-Selenium-Sodium Sigma-Aldrich  
iTaq Universal SYBR Green Supermix BioRad 172-5125 
Knockout DMEM Invitrogen 10829-018 
Knockout serum replacement Invitrogen 10828-028 
Leukemia inhibitory factor, mouse Millipore ESG1107 
Leukemia inhibitory factor, recombinant human Millipore LIF1010 
L-glutamine Invitrogen 25030-081 
Lipofectamine 2000 Invitrogen 11668-019 
MACS MS column Miltenyi Biotec 130-042-201 
MACS MultiStand  Miltenyi Biotec 130-042-303 
Matrigel Matrix High Concentration, Growth Factor 
Reduced *LDEV-Free 
BD Biosciences 354263 
MiniMACS Separator Miltenyi Biotec 130-042-102 
M-MLV Reverse Transcriptase Affymetrix 78306 
Neurobasal medium Invitrogen 12348-017 
Nonessential amino acids PAA M11-003 
NucleoBond Xtra Maxi MACHEREY-
NAGEL 
740416.5 
Nucleofector II device Lonza  
N2 supplement Invitrogen 17502-048 
Opti-MEM Invitrogen 31985062 
Penicillin /streptomycin PAA P11-010 
Penicillin /streptomycin /glutamine PAA P11-013 
PD0325901 Stemgent 04-0006 
pCRII TOPO vector Invitrogen K4650-40 
pEGFP-1 vector Clontech 6086-1 
pMD2.G Addgene 12259 
psPAX2 Addgene 12260 
Phusion High-Fidelity DNA Polymerase Thermo Fisher F530 
QIAquick PCR Purification Kit QIAGEN 28106 
QIAquick Gel Extraction Kit QIAGEN 28704 
PRDM14 shRNA lentiviral knockdown constructs Thermo Fisher RHS4533-EG63978 
RPMI 1640 PAA E15-039 
RNeasy Micro Kit QIAGEN 74004 
Sodium pyruvate PAA S11-003 
Stem cell factor, recombinant mouse Millipore GF141 
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Stem cell factor, recombinant human Invitrogen PHC2116 
Streptavidin-Cy3 GE Healthcare PA43001 
TOP10 Chemically Competent E. coli Invitrogen C4040-10 
TrypLE express enzyme, no phenol red Invitrogen 12604-021 
Trypsin-EDTA 0.25%, phenol red Invitrogen 25200-056 
T4 ligase Roche 10799009001 
WNT3A, recombinant human R&D systems 5036-WN-010 
XhoI Fermentas FD0694 
Y-27632 dihydrochloride Abcam 
Biochemicals 
ab120129 
ZR Plasmid Miniprep ZYMO research D4015 
2-mercaptoethanol Invitrogen 31350-010 
 
2.1.2. Equipment 
Name Manufacture Catalogue number 
Conical tube, 15 ml SARSTEDT 62.554.002 
Conical tube, 50 ml SARSTEDT 62.547.004 
Culture plate, 10 cm SARSTEDT 83.1802 
Culture plate, 12 well Nunc 150628 
Culture plate, 15 cm SARSTEDT 83.1803 
Culture plate, 6 cm SARSTEDT 83.1801 
Culture plate, 6 cm suspension Corning 430589 
Culture plate, 6 well SARSTEDT 83.§839 
Culture plate, 96 well U-Bottom Ultra Low Attachment  Corning 7007 
CryoTube vial Nunc 377244 
Cell strainer, 40 μm BD Biosciences 352340 
Cell strainer, 70 μm BD Biosciences 351350 
Vacuum Filter, 0.22 "m Corning 431153 
 
2.2. Methods 
2.2.1. Animals 
The SCID mice used in this study were raised in a temperature and humidity 
controlled animal facility with a 12 hr light- dark cycle controlled environment at a 
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temperature of 22 ± 1 °C and 35 ± 5 % humidity. All the animal experiments were 
performed under the ethical guidelines of the Max Planck Institute. 
 
2.2.2. Cell culture medium 
MEF medium 
• DMEM Low Glucose  
• 15% Fetal bovine serum Gold  
• 1x Penicillin /streptomycin /glutamine  
 
Mouse ESC medium 
• Knockout DMEM  
• 15% Knockout serum replacement  
• 1x Penicillin /streptomycin /glutamine  
• 1x Nonessential amino acids  
• 0.1 mM #-Mercaptoethanol 
• 1,000 units/ml Leukemia inhibitory factor, mouse  
 
Mouse PGC medium (serum-containing) 
• DMEM high Glucose  
• 15% Fetal bovine serum  
• 1x Penicillin /streptomycin /glutamine  
• 1x Nonessential amino acids  
• 0.1 mM #-Mercaptoethanol 
 
 
Mouse PGC medium (serum-free) 
• modified $MEM 
• 3 mg/mL Bovine serum albumin  
• 1x Penicillin /streptomycin  
• 2 mM L-glutamine  
• 0.23 mM Sodium pyruvate (Invitrogen) 
• 1x Insulin-Transferrin-Selenium-Sodium (Invitrogen) 
• 1 ng/ml Epidermal growth factor, recombinant human 
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• 50 ng/ml Stem cell factor, recombinant mouse 
 
Mouse oocyte growth media 
• modified$MEM 
• 3 mg/mL Bovine serum albumin  
• 1x Penicillin /streptomycin  
• 0.23 mM Sodium pyruvate (Invitrogen) 
• 5mg/mL Insulin, 5mg/mL Transferrin, 5ng/mL Selenium (Sigma-Aldrich) 
• 1 ng/ml Epidermal growth factor, recombinant human  
• 5 ng/mL Follicle stimulating hormone, recombinant human 
 
Mouse oocyte maturation medium 
• modified $MEM 
• 3 mg/mL Bovine serum albumin  
• 1x Penicillin /streptomycin  
• 0.23 mM Sodium pyruvate (Invitrogen) 
• 5mg/mL Insulin, 5mg/mL Transferrin, 5ng/mL Selenium (Sigma-Aldrich) 
• 1 ng/ml Epidermal growth factor, recombinant human  
• 100 ng/mL Follicle stimulating hormone, recombinant human 
 
Human ESC medium 
• Knockout DMEM  
• 20% Knockout serum replacement  
• 1x Penicillin /streptomycin /glutamine  
• 1x Nonessential amino acids  
• 0.1 mM #-Mercaptoethanol 
• 5 ng/ml FGF-basic, recombinant human  
 
Human PGC precursor medium (unless stated otherwise) 
• DMEM/F-12  
• 1x N2 supplement   
• 1x B27 supplement minus vitamin A  
• 1x Penicillin /streptomycin /glutamine  
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• 1x Nonessential amino acids  
• 0.1 mM #-Mercaptoethanol 
• 0.5% (wt/vol) bovine serum albumin  
• 50 ng/ml Activin A, recombinant human/mouse/rat  
• 5 ng/ml BMP4, career-free, recombinant human  
• 20 ng/ml FGF-basic, recombinant human  
• 10 ng/ml FGF-basic, recombinan 
 
In some experiments, the following cytokine was added to the medium 
• 100 ng/ml WNT3A, recombinant human 
 
GK20 medium (Human PGC medium) (unless stated otherwise) 
• GMEM  
• 20% Knockout serum replacement  
• 10 mM Sodium pyruvate (PAA) 
• 1x Penicillin /streptomycin /glutamine  
• 1x Nonessential amino acids  
• 0.1 mM #-Mercaptoethanol 
• 20 "M Y-27632 dihydrochloride  
 
For the PGC differentiation, the following cytokines were added to the medium 
• 100 ng/ml BMP4, career-free, recombinant human  
• 20 ng/ml Leukemia inhibitory factor, recombinant human  
 
In some experiments, the following cytokine was added to the medium 
• 0.5-100 ng/ml Stem cell factor, recombinant human 
 
RPMI medium 
• RPMI 1640  
• 15% Fetal bovine serum Gold  
• 1x Penicillin /streptomycin /glutamine  
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Cell freezing medium 
• The corresponding medium for cell lines without cytokines or chemicals 
• 20% DMSO 
• 10  "M Y-27632 dihydrochloride (only for human ESCs and iPSCs) 
 
2.2.3. Cell culture  
2.2.3.1. Derivation of MEF 
MEFs were generated from E12.5 dpc embryos of C57BL/6, C3H, or CF1 mice. The 
pregnant female mice were sacrificed by cervical dislocation and extraembryonic 
membranes and placentas were removed and placed in PBS. The uteri were isolated 
and the embryos were removed and immersed in PBS. After decapitation of the 
embryos, heart and liver as well as the extremities were removed and the remaining 
embryos were placed in MEF medium. The embryos were cut into small pieces with 
scissors and digested with 0.05% Trypsin/EDTA for 4 min at 37 °C. The tissue was 
further digested with a 4 to 1 dilution of 0.05% Trypsin/EDTA with MEF medium. 
Subsequently, the digests were filtered through a 100 "m cell strainer and the cell 
suspension was centrifuged at 1,000 rpm for 5 min and then plated onto gelatinized 
plates at a density of 2-3 embryos per 15 cm tissue culture dish and cultivated at 
37 °C with 5% CO2 in a humidified incubator. 
 
2.2.3.2. MEF culture 
MEFs were cultured in MEF medium on 0.1 % gelatin-coated 15-cm plates (2.0 x 106 
cell/dish) at 37 °C with 8.5 % CO2. The cells were passaged every other day by 
0.25% Trypsin/EDTA dissociation of the culture into single cells until passage 
number 3. The cells were then mitotically inactivated by irradiation at 1 gy/min for 45 
min and stored in freezing medium in liquid nitrogen. 
 
2.2.3.3. Preparation of MEF-conditioned medium (MEF-CM) 
Irradiated MEFs (CF1) were plated at 56,000 cells/cm2 in MEF medium. To condition 
medium, MEF medium was replaced with human ESC medium (0.5 ml/cm2). MEF-
CM was collected and replaced with fresh human ES medium every day for 1 week. 
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The collected MEF-CM was then filtered (0.22 number 3), aliquoted and frozen at -
20oC. 
 
2.2.3.4. Preparation of coated-plates 
Gelatin-coated plates 
Tissue culture dishes of the required size were coated with a layer of 0.1% gelatin in 
sterile PBS and incubated at 37 °C for 1 hr in a humidified incubator.  
 
FBS-coated plates 
Tissue culture dishes of the required size were coated with a layer of FBS and 
incubated at room temperature for 1 hr.  
 
Matrigel-coated plates 
Matrigel was thawed on ice overnight and then diluted 1:3 with ice-cold knockout 
DMEM. 1-ml aliquotes were then frozen at -20oC as stocks. For coating of plates, 
each 1-ml stock was diluted with 24 ml of knockout DMEM on ice (1:75 total 
dilution). Precooled 6- or 12-well plates were covered with 1ml or 0.4ml of diluted 
matrigel, respectively. Plates were then wrapped in parafilm and kept at room 
temperature overnight. The next day, plates were transferred to 4 °C for at least 1 day. 
 
2.2.3.5. Mouse ESC culture 
Mouse ESCs were cultured either in mouse ESC medium on irradiated MEF 
(C57BL/6 or C3H)-coated plates or in mouse N2B27+2i medium on poly-L-
ornithine/laminin-coated plates. The cells were passaged every other day by accutase 
dissociation of the culture into single cells. 
 
2.2.3.6. Mouse EpiScs and Δouse EpiScs+ EpiSCs culture 
Mouse EpiSCs and Δ and EpiSCs+ EpiSCs were cultured in MEF-CM supplemented 
with 5 ng/ml human bFGF at 37 °C with 5% CO2 on FBS-coated plates. The medium 
was changed every day and the cells were passaged every 4–6 days by accutase 
dissociation of the culture into single cells. 
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2.2.3.7. Mouse PGC differentiation 
Mouse ESC lines (gcOct4-GFP (XY) and OG2 (ΔPE-Oct4-GFP, XY; XX)) were 
differentiated into oocytes according to 3 protocols: a serum-containing protocol, a 
serum-containing/serum-free differentiation combination protocol, and a serum-free 
differentiation protocol. Briefly, for the serum-containing differentiation procedure, 
cells were grown in tissue culture plates in mouse PGC medium (serum-containing) in 
the absence of MEF feeder cells and LIF for up to 30 days. The medium was changed 
every 3 days for 9 days and every other day thereafter. Floating cell aggregates after 
day 12 of differentiation were collected and processed as published (Hubner et al, 
2003). 
 
For the serum-containing/serum-free differentiation combination technique, ESCs 
were differentiated under serum-containing conditions for 7–12 days. The adherent 
cell layer was digested with accutase and the single-cell suspension was then plated as 
a suspension culture at a 1:1 ratio in serum-free PGC medium in a humidified 
incubator at 37 °C in 5% O2 and 5% CO2. Cells were cultured for 7–15 days, and 
putative oocytes were then individually picked with a drawn-out glass capillary. 
 
For the serum-free differentiation protocol, feeder-free ESCs were plated on gelatin-
coated tissue culture plates in mouse N2B27 medium supplemented with 10 ng/ml 
Bmp4 and 1,000 units/ml LIF and cultured for 48 h. The adherent cell layer was then 
digested with accutase and the single-cell suspension was replated at a 1:2 ratio in 
IVG media supplemented with SCF (100 ng/ml) and LIF (1,000 units/ml) in 
suspension plates. After 3 days of culture, cell aggregates were transferred to 
gelatinized 24-well tissue culture plates at a density of 5–6 aggregates per well and 
further cultivated for 5 days in medium lacking LIF. Cultures were then partially 
digested in 0.05% trypsin/ EDTA supplemented with 0.02% DNase I, replated in 
oocyte growth media and cultured in a humidified incubator at 37°C in 5% O2 and 
5% CO2 for additional 12–15 days. Putative oocytes were cultivated in maturation 
medium. 
 
2.2.3.8. Human ESC and iPSC culture 
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Human ESCs and iPSCs were cultured in MEF-CM supplemented with 5 ng/ml 
human bFGF at 37 °C and 5% CO2 on Matrigel-coated plates and used at a passage 
number below 50. The medium was changed every day and the cells were passaged 
every 4–6 days by collagenase IV (1 mg/ml) dissociation of the culture into cell 
clumps. 
 
2.2.3.9. Human PGC precursor and PGC differentiation 
To induce differentiation, human ESCs and iPSCs were dissociated into single cells 
by TrypLE and plated on a matrigel-coated well of a 12-well plate (2.0 x 105 
cells/well) in PGC precursor medium. After 48 hours, cells were dissociated by 
TrypLE and plated in a well of an ultra-low-attachment U-bottom 96-well plate in 
human PGC medium (9,000 cells/well). 
 
2.2.4. Amplification of STELLA promoter sequence 
5 kbps of human STELLA promoter was amplified by PCR from genomic DNA of 
human ESCs (H9 human ESCs) using Phusion High-Fidelity DNA Polymerase. The 
condition and primers used for amplification are described below. The PCR products 
were analyzed by electrophoresis. Bands with expected product size were cut out of 
the gel and purified using the QIAquick Gel Extraction Kit according to the 
manufacture’s protocol. 
 
98 °C 30 sec  
98 °C 10 sec 
40 cycles 60 °C 30 sec 
72 °C 2 min 
72 °C 10 min  
4 °C ∞  
 
 Primer sequence (5'-3') Product size (bp) 
STELLA 
promoter 
Fw: TAGTTAGAGCTCATTCTCGAGAACAGCAGGTGCTGAAGG 
4739 
Rv: TATTGAATTCAATTAAGCTTGATCGCCTAGGGGCTTAAC 
TEX13B 
promoter 
Fw: TAGTTAGAGCTCATTCTCGAGGCTGCATGTTGGTAGGGTTT 
4659 
Rv: TATTGAATTCAATTAAGCTTCGGCGTCTTGACACAACACT 
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2.2.5. Ligation of the STELLA promoter sequence into pEGFP-1 vector 
The PCR fragments and the pEGFP-1 plasmid were digested with  HindIII and XhoI 
in FastDigest Green Buffer at 37 °C for 4 hr. The digested samples were purified 
using the QIAquick PCR Purification Kit according to the manufacture’s protocol. 
The STELLA promoter fragment was then ligated into the pEGFP-1 vector using T4 
ligase overnight at 16 °C.  
 
2.2.6. Transformation of competent bacterial cells 
50 µl of TOP10 Chemically Competent E. coli cells were thawed on ice for 10 min, 
mixed with 6-25 µl of the ligation reaction mix and placed on ice for 30 min and 
occasionally mixed. The transformation reaction mixture was heat shocked at 42 °C 
for 30 sec and immediately placed on ice for 5 min. 180 e tranLB medium was added 
to the reaction mixture and incubated at 37 °C with shaking for 1 hr. Cells were then 
plated on LB-agar plates containing kanamycin and incubated overnight at 37 °C in 
an upside-down position. 
 
2.2.7. Plasmid DNA preparation 
Individual transformed E. coli colonies were picked up and cultivated in 2 ml LB 
medium containing kanamycin at 37 °C for 16 hr. Plasmid DNA was isolated from 1 
ml bacterial cultures using the ZR Plasmid Miniprep kit according to the 
manufacturer’s protocol. For selection of clones containing the appropriate plasmid, 
the purified plasmids were digested with HindIII and analyzed by agarose gel 
electrophoresis. Samples that showed expected band size were further cultivated in 
200 ml LB medium containing kanamycin at 37°C for 16 hr and purified using 
NucleoBond Xtra Maxi kit according to the manufacturer’s protocol. Purified 
plasmids were stored at -20 °C until use. 
 
2.2.8.  Generation of STELLA-GFP human ESCs and iPSCs 
For the generation of stable GFP reporter lines, the STELLA-GFP transgene was 
transfected using the Human Stem Cell Nucleofector Kit and Nucleofector II device 
according to the manufacturer’s protocol. Briefly, human ESCs or iPSCs were 
pretreated with 10 "M Y-27632 dihydrochloride for 1 hour and dissociated into single 
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cells by TrypLE. 2 x 106 cells were resuspended in 100 "l nucleofection solution and 
incubated at 37 °C for 5 min. Then, 4 "g plasmid DNA were added to the cell 
suspension and transferred to the provided cuvette avoiding air bubbles. 
Nucleofection was performed with the A-23 program. After nucleofection, 500 "l 
pre-warmed RPMI medium was added to the cuvette, transferred to Eppendorf tubes 
and incubated at 37 °C for 5 min. The cell suspension was plated onto 1 well of a 6-
well plate in hESC medium with 10 "M Y-27632 dihydrochloride. Transgene 
selection was done under standard human ESC/iPSC condition supplemented with 
G418 (200 "g/ml) from day 3 for 2 weeks. After the selection, individual colonies 
were clonally expanded for further experiments. 
 
2.2.9. Lentivirus Production 
Lentivirus were produced by transfecting the lentivirus constructs psPAX2 and 
pMD2.G using Lipofectamine 2000. Briefly, 12 mg of the lentivirus construct, 9 mg 
psPAX2 and 3 mg pMD2.G were mixed into 1.5 ml Opti-MEM. In parallel, 45 "l 
Lipofectamine 2000 was gently mixed with 1.5 ml fresh Opti-MEM and incubated at 
room temperature for 5 min. DNAs and Lipofectamine were then gently mixed and 
incubated at room temperature for 20 min to allow DNA and lipid to form complexes. 
The DNA-Lipofectamine complexes (3 ml) were dropped onto a 10 cm dish of 2.2 x 
106 293T HEK cells in 6 ml Opti-MEM (total 9 ml) and incubated at 37 °C for 5 hr. 
The medium was replaced with MEF medium lacking antibiotics and incubated at 
37 °C and 5 % CO2. The supernatant was collected every day for 2 days and the virus 
was concentrated by ultracentrifugation at 26,000 rpm for 2 hours at 4 °C. Viral 
pellets were resuspended in 1ml knockout DMEM and stored at -80 °C. 
 
2.2.10. Knock-down of BLIMP1 and PRDM14 
BLIMP1 and PRDM14 shRNA lentiviral knockdown constructs were purchased from 
Thermo Fisher. The Lentivirus were produced as described in section 3.2.3.15. For 
infection of cells, iPSCs pretreated with 10 μM Y-27632 dihydrochloride for 1hr 
were dissociated into single cells by TrypLE. 1 x105 cells in 1 ml of human ESC 
medium were infected with 60 "l of concentrated virus in 15 ml tubes and incubated 
at 37°C and 5% CO2 for 5 hr with occasional mixing. Thereafter, cells were washed 
with PBS three times and used for experiments. 
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2.2.11. Fluorescence-Activated Cell Sorting Analysis 
Aggregates were dissociated with 0.25% Trypsin/EDTA supplemented with 2% 
chicken serum (37°C, 30 min). Dissociated cells were incubated with anti-TRA-1-81 
antibody (eBioscience, cat. no. 14-8883) and anti-c-KIT antibody (eBioscience, cat. 
no. 550412) conjugated with PE and APC, respectively, on ice for 30 min. The cells 
were then washed three times with PBS supplemented with 5% FBS and analyzed on 
a flow cytometer. 
 
2.2.12. Immunocytochemistry  
Cells were fixed with 4% paraformaldehyde for 15 min, permeabilized with 0.2–1% 
Triton X-100 for 10 min, and blocked with a solution comprising 2% BSA, 5% FBS, 
and 0.1% Tween 20 in PBS for 45 min. For 5mC, cells were treated with 4N HCl for 
30 min at room temperature before blocking. Primary and secondary antibodies were 
applied overnight at 4°C and for 1 h at room temperature, respectively, in 0.5% BSA 
in PBS-T. Hoechst stain was applied to the second-to-last washing step at 1 "g/ml. 
The primary antibodies used in this study were as follows: OCT4 (1:100), BLIMP1 
(1:100), T (1:100), STELLA (1:100), and 5mC (1:100).  
 
2.2.13. Real-Time PCR (qPCR) 
Total RNA from cells was extracted and purified using the RNeasy Micro Kit. For 
qPCR, total RNA was reverse transcribed by M-MLV Reverse Transcriptase and the 
resultant cDNA was used for qPCR analysis. qPCR was performed with iTaq 
Universal SYBR Green Supermix and 0.375 "g total RNA.  
 
 
Primer sequence (5'-3') Product size (bps) 
OCT4 
F: GGAAGGAATTGGGAACACAAAGG 
71 
R: AACTTCACCTTCCCTCCAACCA 
NANOG 
F: CCTGTGATTTGTGGGCCTG 
78 
R: GACAGTCTCCGTGTGAGGCAT 
SOX2 
F: TGGCGAACCATCTCTGTGGT 
111 
R: CCAACGGTGTCAACCTGCAT 
T 
F: CCTTGCTCACACCTGCAGTAGC 
79 
R: GGCCAACTGCATCATCTCCA 
BLIMP1 F: AGGAAAGGACCTCTACCGTTC 118 
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R: GATGGGGTAAACGACCCGAG 
STELLA 
F: CATGTTACTCGGCGGAGT 
63 
R: ACTCCCTTAGGCTCCTTG 
c-KIT 
F: ACTTGAGGTTTATTCCTGACCCC 
78 
R: GCAGACAGAGCCGATGGTAG 
HAND1 
F: TCCCTTTTCCGCTTGCTCTC 
114 
R: CATCGCCTACCTGATGGACG 
CDX2 
F: TCACTACAGTCGCTACATCACCATC 
78 
R: TTAACCTGCCTCTCAGAGAGCC 
PAX6 
F: CCAGGGCAATCGGTGGTAGT 
84 
R: ACGGGCACTCCCGCTTATAC 
MIXL1 
F: CAGAACAGGCGTGCCAAGTC 
94 
R: TTCCAGGAGCACAGTGGTTGA 
MESP1 
F: CAACTGACGCCGTCTCTGTGA 
71 
R: GTCTGCCAAGGAACCACTTCG 
GSC 
F: ACCTCCGCGAGGAGAAAGTG 
101 
R: CTTCTCCGCGTTCTCCGACT 
EOMES 
F: CGGCCTCTGTGGCTCAAA 
76 
R: AAGGAAACATGCGCCTGC 
GATA4 
F: AATGACTCCAGAACAACAACTGGG 
111 
R: CTCCCTCCAGTCCCATCAGC 
GATA6 
F: TGTGCGTTCATGGAGAAGATCA 
83 
R: TTTGATAAGAGACCTCATGAACCGACT 
NPNT 
F: GTAAGCACAGGTGCATGAACA 
79 
R: GAACCATCCGGCATGAGCATA 
SOX17 
F: TTCGTGTGCAAGCCTGAGATG 
99 
R: GTCGGACACCACCGAGGAA 
GAPDH 
F: CTGGTAAAGTGGATATTGTTGCCAT 
81 
R: TGGAATCATATTGGAACATGTAAACC 
ACTB 
F: TCAAGATCATTGCTCCTCCTGAG 
87 
R: ACATCTGCTGGAAGGTGGACA 
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2.2.14. Microarray analysis 
For microarray, total RNA was used as input into a linear amplification protocol 
(Illumina TotalPrep RNA Amplification Kit), which involved synthesis of T7-linked 
double-stranded cDNA and 12 h of in vitro transcription incorporating biotin-labeled 
nucleotides. Purified and labeled cRNA was then hybridized for 18 h onto HumanHT-
12 v4 expression BeadChips (Illumina) following the manufacturer’s instructions. 
After washing as recommended, chips were stained with streptavidin-Cy3 (GE 
Healthcare) and scanned using the iScan reader (Illumina) and accompanying 
software. Samples were exclusively hybridized as biological replicates. 
 
2.2.15. Microarray data processing (performed by Araúzo-Bravo, Marcos J) 
The bead intensities were mapped to gene information using BeadStudio 3.2 
(Illumina). Background correction was performed using the Affymetrix Robust Multi-
array Analysis (RMA) background correction model (Irizarry et al, 2003). Variance 
stabilization was performed using the log2 scaling and gene expression normalization 
was calculated with the method implemented in the lumi package of R-Bioconductor. 
Data post-processing and graphics was performed with in-house developed functions 
in Matlab. Hierarchical clustering of genes and samples was performed with one 
minus correlation metric and the unweighted average distance (UPGMA) (also known 
as group average) linkage method.  
 
The gene ontology terms were taken from the AMIGO gene ontology database 
(Ashburner et al, 2000). The significance of the gene ontology terms of the different 
expressed genes was analyzed using an enrichment approach based on the 
hypergeometric distribution. All the sets of gene ontology terms were back 
propagated from the final term appearing in the gene annotation to the root term of 
each ontology. The significance (p-value) of the gene ontology terms enrichment was 
calculated using the hypergeometric distribution. The multitest effect influence was 
corrected through controlling the false discovery rate using the Benjamini-Hochberg 
correction at a significance level. 
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The data discussed in this publication have been deposited in NCBI’s Gene 
Expression Omnibus and are accessible through GEO Series accession number 
GSE53498.  
 
2.2.16. Bisulfite Sequencing 
PCR products were purified using either QIAquick gel extraction kit or PCR 
purification kit (Qiagen), cloned into TOPO vector (Invitrogen), and then 
subsequently transformed into TOP10 E. Coli . Individual colonies were inoculated 
into LB medium containing Kanamycin (50 μg/ml) and cultured overnight in a 37°C 
shaking incubator. Plasmids were extracted using the ZR Plasmid Miniprep kit. Ten 
insert-containing colonies (determined by the EcoRI digestion) were sequenced with 
the M13 forward primer. 
  
To determine the DNA methylation status at regulatory regions of imprinted genes, 
bisulfite conversion was carried out on 2 "g of isolated genomic DNA with the 
EpiTect Bisulfite Kit according to the manufacturer’s protocol. The bisulfite-
converted DNA was amplified by PCR using the condition and primers according to a 
previous study (Kim et al, 2007). Briefly, PCR was performed in a 25 "l reaction 
volume, with 0.625 units of Hotstar Taq polymerase (Qiagen), 1% supplied reaction 
buffer, 0.5 "M of each primer, 1.5–2.5 mM of MgCl2, 0.25 mM of dNTP (Invitrogen), 
and 50 ng of each DNA template. The PCR cycling conditions were as described 
below. 
 
95 °C 15 min  
95 °C 1 min 
40 cycle 58 °C 30 sec 
72 °C 1 min 
72 °C 9 min 
4 °C ∞  
 
Thereafter, the PCR products were cloned into the pCRII TOPO vector according to 
the manufacturer’s protocol. Individual clones were sequenced with the M13 forward 
primer by GATC-biotech (http://www.gatc-biotech.com/en/index.html). Sequences 
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were analyzed using the Quantification Tool for Methylation Analysis (QUMA, 
http://quma.cdb.riken.jp). 
 
 
Primer sequence (5'-3') Product size (bps) 
PEG1 DMR 
F: TYGTTGTTGGTTAGTTTTGTAYGGTT 
290 
R: AAAAATAACACCCCCTCCTCAAAT 
KvDMR1 
F: TGATGTGTTTATTATTTYGGGG 
304 
R: CCCTAAAATCCCAAATCCTC 
PEG10 DMR 
F: GGTGTAATTTATATAAGGTTTATAGTTTG 
234 
R: AACAAAAAAAATAAAATCCCACAC 
NESP55 DMR 
F: TTTTTGTAGAGTTAGAGGGTAGGT 
344 
R: AAAAAAAACAACTCAAAATCTACC 
M13 F: GTAAAACGACGGCCAGT 
 
 
2.2.17. Transplantation of reconstituted ovaries under the ovarian bursa 
Generation of reconstituted ovaries and transplantation under the ovarian bursa of 
mice was carried out according to a published protocol with slight modifications 
(Hayashi & Saitou, 2013). Briefly, fluorescence-activated cell sorting (FACS)-sorted 
d4 TRA-1-81+/c-KIT+ cells were re-aggregated with embryonic day (E) 12.5 gonadal 
somatic cells at a ratio of 5,000:50,000. For this, female gonads were collected from 
embryos at E12.5. The mesonephri were surgically separated from the gonads using 
tungsten needles. The gonads were dissociated with 0.05% Trypsin/EDTA 
supplemented with 0.02% DNase I (10–15 min, 37°C) and endogenous PGCs were 
removed by magnetic cell sorting using anti-SSEA1 antibody conjugated with 
magnetic beads and MACS MS column according to the manufacturer’s protocol. The 
resulting gonadal somatic cells and FACS-sorted PGCLCs were plated in the wells of 
a low-cell–binding U-bottom 96-well lipid-coated plate in GK20. After 2 days of 
culture in GK20, the reconstituted ovaries were transplanted under the ovarian bursa. 
Briefly, two reconstituted ovaries were inserted with a glass capillary through a slit 
under the ovarian bursa of 4-week-old SCID female mice that had been anesthetized. 
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Transplanted ovaries were then collected from the recipient female mice 3 months 
after transplantation. 
 
2.2.18. Electron microscopy (performed by Psathaki, O. E.) 
For transmission electron microscopy (TEM), cells were fixed with 2.5% 
glutaraldehyde (Merck) in 0.1 M sodium cacodylate buffer (pH 7.4), postfixed in 1% 
aqueous osmium tetroxide, dehydrated stepwise in a graded ethanol series, and 
embedded in Epon 812 (Fluka, Buchs, Switzerland). Ultrathin (50 nm) sections were 
prepared with an ultramicrotome (EM UC6; Leica), stained first with 1% uranyl 
acetate and then with 3% lead citrate, and subsequently examined using a Zeiss EM 
109 electron microscope (Zeiss). Images were taken on 70 mm films (Maco ORT 25c 
orthochromatic; Hans O. Mahn & Co., Photo Division). 
 
For scanning electron microscopy (SEM), cells were fixed with 2.5% glutaraldehyde 
in 0.1 M phosphate buffered saline (pH 7.4) and dehydrated stepwise in a graded 
ethanol series. Samples were dried with 100% ethanol via CO2 in a critical- point 
apparatus (Balzers). Dried samples were mounted onto aluminum stubs with leit-tabs 
and coated with gold film to a thickness of 40–50 nm in a sputter coater (Leitz). Cells 
were viewed under a Hitachi S-530 scanning electron microscope operated in a 
secondary mode at 20 kV. 
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3. Results 
3.1. PGC differentiation from human ESCs and iPSCs 
3.1.1. Examination of in-house protocol and published protocol for PGC 
differentiation from human ESCs 
A study on human PGC differentiation was reported demonstrating that serum-based 
medium supplemented with BMP4 sufficiently induces VASA-GFP+ putative PGCs 
(up to 5%) (Kee et al, 2009). I therefore assessed if the protocol works similarly in 
our laboratory. To this end, I differentiated human ESCs according to the study and 
analyzed expression levels of OCT4, BLIMP1, PRDM14, STELLA, SYCP3, LHX8 and 
NOBOX on day 2, 5, 10 and 15. As shown in Figure 3A, the serum-based 
differentiation procedure generated very similar expression changes as the mouse 
protocol, with the exception that STELLA expression was significantly downregulated. 
To further substantiate PGC identity, I analyzed SSEA1 and c-KIT expression in my 
cultures, since a previous study had demonstrated that post-migratory human PGCs 
could be distinguished from other cell types by those two surface antigens (Park et al, 
2009). Although the publication reported induction of up to 5% PGC-like cells after 
14 days of differentiation, I barely found SSEA-1+/c-KIT+ cells, independent of cell 
lines used (Figure 3B). This outcome is most probably due to common serum lot 
differences indicate that serum-based conditions are uncontrollable and therefore 
difficult to reproduce between different laboratories. 
 
I then assessed the protocol, which we had developed to differentiate PGCs from 
mouse ESCs (Psathaki et al, 2011). I differentiated human ESCs following the mouse 
protocol and again analyzed expression levels of OCT4, BLIMP1, PRDM14, STELLA, 
SYCP3, LHX8 and NOBOX on day 2, 5, 10 and 15. As shown in Figure 4A, OCT4 
and PRDM14 were strongly downregulated upon differentiation, indicating the loss of 
pluripotency in the culture, as these genes are known to be involved in pluripotency. 
The early PGC genes BLIMP1 got upregulated on day 2 (4-fold) and then 
downregulatd on later days. STELLA was slightly upregulated on day 2 (1.5-fold), but 
downregulated on later days (0.7-fold). NOBOX did not show significant expression 
change. On the other hand, the meiotic gene SYCP3 was upregulated on day 2, 
however, became undetectable on day 10 and 15. Interestingly, the late PGC gene 
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LHX8 was upregulated on day2 (25-fold) and its expression level further increased 
until day 15 (81-fold).  I interpreted this observation as an indication for the presence 
of putative PGCs. I then assessed if this condition could induce SSEA-1+/c-KIT+ 
putative PGCs. However, this condition proved insufficient to induce putative PGCs, 
as I did not observe a significant induction of SSEA-1+/c-KIT+ cell population from 
three independent human ESCs and iPSC lines (Figure 4B). These data demonstrated 
that the mouse protocol works insufficiently to induce putative PGCs from human 
ESCs. 
 
 
 
Figure 3 Differentiation of human pluripotent stem cells by a published protocol. (A) Gene expression 
dynamics in bulk cultures during differentiation. The value for ESCs is set as 1, and values are on log2 
scale. N.D.: not detectable (B) FACS analysis of SSEA-1+/c-KIT+ cells from three independent ESC 
and iPSC lines.  
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Figure 4 Differentiation of human pluripotent stem cells by the mouse PGC induction protocol. (A) 
Gene expression dynamics in bulk cultures during differentiation. The value for ESCs is set as 1, and 
values are on log2 scale. N.D.: not detectable (B) FACS analysis of SSEA-1+/c-KIT+ cells from three 
independent ESC and iPSC lines. 
Next, I asked whether human ESCs contain a subpopulation of BLIMP+ PGC 
precursor, similar to mouse ESCs. In mouse, it is known that mouse EpiSCs contain a 
subpopulation of Bimp1+ (10-50 %) cells and Stella+ cells (0-1.5 %) (Hayashi & 
Surani, 2009). I performed immunofluorescent analysis for OCT4 and BLIMP1 in 
undifferentiated human ESCs. As shown in Figure 5, I could not detect any BLIMP1+ 
cells in OCT4+ human ESCs. I therefore concluded that human ESCs do not contain a 
sub-population of PGC and, thus, demonstrate a different character from mouse 
EpiSCs. 
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Figure 5 Immunofluorescence analysis of undifferentiated human ESCs. Scale bar: 75 dif 
3.1.2.Search for a candidate gene for PGC identification 
Based on the results of the initial experiments, I set out to develop a new serum-free, 
directed differentiation protocol for the reproducible and efficient induction of germ 
cells from human pluripotent stem cells. To monitor early PGC induction in the 
complex cell mixture within differentiation cultures, I decided to engineer a GFP 
reporter construct and generate stably transfected ESC and iPSC cell lines. One of the 
known earliest human PGC genes is BLIMP1 (see introduction). However, BLIMP1 is 
known to be expressed in other somatic cell types, such as B cells (Turner et al, 1994), 
differentiating macrophages (Chang et al, 2000) and a subset of T-cells (Kallies et al, 
2006; Martins et al, 2006). Therefore, I sought genes that exhibit a similar expression 
pattern as BLIMP1 but would not be expressed in other cell types. To this end, I 
differentiated human ESCs in directed conditions by promoting or inhibiting BMP, 
TGF and FGF signaling (table 3), and assessed the expression pattern and level of 
the pluripotency genes OCT4, NANOG and SOX2, and the PGC genes BLIMP1 and 
STELLA, on day 7. In addition, I included 9 genes that were previously found to be 
specifically upregulated in 11.5-16.5 dpc mouse germ cells as compared to ESCs, 
namely PLCL2, TDRKH, FKBP6, MOV10L1, C4ORF48, PIK3R3, AKT3, TEX13B 
and C19ORF57 (Sabour et al, 2011). As shown figure 6A, OCT4 and NANOG were 
strongly downregulated in all conditioned. In contrast, SOX2 was slightly upregulated 
when BMP signaling was inhibited. Interestingly, BLIMP1 and STELLA were 
upregulated coincidently when BMP signaling was inhibited and WNT signaling was 
activated. Furthermore, among the genes that had been identified in the mouse study, 
FKBP6 and TEX13B were upregulated in the condition that upregulated BLIMP1 and 
STELLA. Interestingly, I did not observe any STELLA+ cells in our cultures, 
indicating that those cultures activate genes associated with germ cells, but not 
sufficient enough to induce bona fide PGCs. Nevertheless, STELLA, FKBP6 and 
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TEX13B exhibited a similar expression pattern to BLIMP1 and thus could potentially 
be used as germ cell specific reporters. In fact, qPCR analysis revealed that STELLA 
and TEX13B were distinctly expressed in the in vitro generated SSEA1+/c-KIT+ cells, 
together with OCT4 and NANOG, again suggesting that these genes could be used as 
specific maker for identifying putative germ cells in humans (Figure 6B).  
 
 
Table 3 List of additives used for differentiation. Concentration of each additive; BMP4: 10 ng/ml, 
Dorsomorphin: 1 eachCHIR99021: 3 μM, SB431542: 10 μM, PD325901: 1 μM. 
 
Additive Function Condition 1 2 3 4 5 6 7 8 9 10 11 
BMP4 BMP activator + + + - + - - - + + - 
Dorsomorphin BMP inhibitor - - - + - + + + - - + 
CHIR99021 WNT activator - - + - + - + + + + + 
SB431542 Activin inhibitor - + - - + + - + - + - 
PD325901 FGF inhibitor - - - - - - - - + + + 
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Figure 6 Expression of germ cell-relate genes in differentiated human ESCs (A) Gene expression 
analysis of human ESCs differentiated by modulating TGFen BMP and FGF signaling pathway. The 
value for ESCs is set as 1, and values are on log2 scale. (B) Gene expression analysis of SSEA-1+/c-
KIT+ putative PGCs. The value for ESCs is set as 1, and values are on log2 scale. 
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3.1.3.Establishment of GFP reporter human pluripotent stem cells 
Next I constructed a GFP-conjugated STELLA and a TEX13B reporter. The promoter 
of these genes was amplified from genomic DNA extracted from human ESCs (H9) 
by PCR. I tested several conditions, for example the presence or absence of DMSO, 
which is known to bind to the DNA at the cytosine residue and thus changes its 
conformation. This makes the DNA more labile for heat denaturation and thus 
enhances amplification. As shown Figure 7A, an enhanced amplification in the 
presence of DMSO is observed, although both approaches efficiently amplified the 
target fragment from gDNA (4739 bps and 4659 bps). Those PCR products were 
ligated into the pEGFP-1 vector (Fig. 7B). The sequence of the obtained construct 
was confirmed by enzymatic digestion and those showing appropriate band size were 
introduced in undifferentiated hESCs and human induced pluripotent stem cells 
(hiPSCs) (Fig. 7C, left two lanes) via transfection.  
 
 
 
Figure 7 Construction of the STELLA and TEX13B reporters. (A) Amplified promoter region of 
STELLA and TEX13B by PCR (B) Schematic map of the pEGFP-1 vector (C) Enzymatic digestion of 
the STELLA-GFP plasmid. 
3.1.4.Differentiation of STELLA-GFP human pluripotent stem cells 
STELLA is known as definitive marker for PGCs in mouse, I therefore utilized 
STELLA-GFP cell lines for further experiments. I first differentiated these cells in 
serum-containing GMEM medium conditions. I did not observe GFP expression in 
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undifferentiated ESCs nor iPSCs, but detected it in some cells within embryoid bodies 
(EBs) (Fig. 8). However, only small numbers of GFP-positive cells were generated. I 
therefore switched to a defined serum-free differentiation conditions containing 
knockout serum replacement (KSR) (GMEM + 20% KSR, hereafter referred to as 
GK20), in which the amount and effect of cytokines can be strictly controlled. GK20 
alone failed to produce any GFP+ cells (Fig. 8). Previous studies have demonstrated 
that BMP4 plays an important role in germ cell induction in both mice and humans 
(Kee et al, 2006; Ohinata et al, 2009). The addition of BMP4 to GK20 led to the 
induction of GFP+ cells, albeit still inefficiently (Fig. 8), demonstrating that the 
culture conditions still needed to be optimized.  
 
 
 
Figure 8 Morphology and GFP signal of undifferentiated STELLA-GFP ESCs and differentiated EBs. 
Scale bar: 100 FP signal of undifferentiated STELLA-GFP ESCs and different 
 
 
Therefore, I attempted to improve the differentiation efficiency using two different 
approaches: 1) the formation of homogeneous EBs from dissociated single cells, and 
2) the pre-differentiation of hPSCs toward early mesoderm–committed PGC 
precursors with the help of known cytokines (Activin A, BMP4, and bFGF).  
 
Spontaneous EB formation of a defined number of single cells resulted in the more 
homogeneous size of EBs compared to the previous approach (Fig. 9A). On the other 
hand, EBs generated by this approach often uncontrollably stuck to each other and 
formed large sized aggregates. In addition, although GFP+ cells were observed in a 
higher number of EBs, a still considerable number of EBs lacked GFP+ cells, 
indicating that formed EBs were still inhomogeneous. To solve this problem, I used 
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ultra-low attachment U-bottom 96-well plates. The ultra-low attachment surface is a 
covalently bound hydrogel layer that is hydrophilic and neutrally charged. Since 
proteins and other biomolecules passively adsorb to polystyrene surfaces through 
either hydrophobic or ionic interactions, this hydrogel surface naturally inhibits 
nonspecific immobilization via these forces, thus inhibiting subsequent cell 
attachment (Fig. 9B). As shown figure 9C, this approach successfully generated 
homogeneous sized EBs from single cells and more importantly, also resulted in a 
homogeneous GFP signal with all EBs containing GFP+ cells. While this approach 
successfully resolved two problems, the formation of equally sized EBs and the 
homogenous distribution of GFP+ cells within each EB, the yield of GFP+ cells in 
each EB was still unsatisfactory and needed to be improved. 
 
 
 
Figure 9 PGC differentiation from single-cell dissociated human ESCs. (A) Spontaneous EB formation 
of single-cell human ESCs (B) The scheme of EB formation by ultra-low attachment U-bottom 96-well 
plates (C) Forced EB formation of single-cell human ESCs by ultra-low attachment U-bottom 96-well 
plates 
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Next, I used a second approach. In mice, PGC specification involves activation of the 
mesodermal program, indicated by the expression of T followed by activation of the 
PGC program (Saitou et al, 2002). Thus, the efficient generation of mesoderm-
committed PGC precursors should support the differentiation of lineage-restricted 
PGCs at a higher efficiency. To proof this idea, I treated the cells with various 
concentrations of Activin A and BMP4 in the presence of bFGF for two days to 
induce mesoderm differentiation, followed by germ cell induction with BMP4 for 
additional 6 days, followed by evaluation of GFP expression (Fig. 10A). As shown in 
Figure 10B, this approach efficiently induced STELLA-GFP+ cells. In addition, 
based on STELLA-GFP expression on day 8, the addition of BMP4 played a crucial 
role in the GFP+ cell induction. This experiment clearly demonstrated that pre-
differentiation of human iPSCs enables the induction of STELLA-GFP signal at high 
efficiency. 
 
 
 
Figure 10 Two-step differentiation of human PSCs towards the germ cell lineage. (A) Schematic 
presentation of the differentiation strategy. (B) STELLA-GFP expression on day 8 of differentiation. 
3.1.5.Differentiation toward mesoderm-committed germ cell precursors 
To dissect the effect of Activin A and BMP4 during the pre-differentiation, I again 
treated the cells with various concentrations of Activin A (ActA) and BMP4 in the 
presence of bFGF for two days to induce differentiation and then analyzed the gene 
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expression profiles of representative pluripotency-associated genes (OCT4, NANOG, 
and SOX2), PGC genes (BLIMP1 and STELLA), and mesodermal genes (T) (Fig. 11). 
The expression level of T was rapidly upregulated by ActA and BMP4, whereas the 
expression levels of OCT4, NANOG, and SOX2 did not change significantly. Based 
on this gene expression dynamics, I observed that at least 50 ng/ml of ActA and 5 
ng/ml of BMP4 were required for activating the T expression level, while maintaining 
similar OCT4 and NANOG expression levels as PSCs. Notably, the expression level 
of BLIMP1 (expressed from 6.5-dpc on in mouse PGCs) was concomitantly 
upregulated, whereas that of STELLA (expressed from 7.5-dpc on in mouse PGCs) 
was not altered. These findings suggested the presence of an intermediate cell state 
between the mesoderm and the germ cell lineage, characterised by mesodermal and 
early PGC gene activation. Taken together, these results indicate that the 
combinational activity of ActA, BMP4, and bFGF is essential for promoting the 
differentiation of human PSCs toward mesoderm-committed germ cell precursors 
mediated by the simultaneous activation of the mesodermal and PGC programs. 
 
 
Figure 11 Effects of Activin A and BMP4 on the expression of selected pluripotency, PGC, and 
mesodermal genes during PGC-precursor induction. All conditions contained bFGF (20 ng/ml). DM: 
dorsomorphin, SB: SB431542. Samples were calibrated with iPSC values, and iPSC values depict 1. 
Y-axes are in log2 scale. 
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Next, I sought to determine whether differentiation for 2 days would maximize the 
induction of mesoderm-committed PGC precursors. To this end, I extended the 
differentiation period to day 7 and analyzed the gene expression dynamics (Figure 
12A). During the entire culture period, expression levels of OCT4, NANOG, SOX2 
and STELLA remained similar to iPSCs levels (we observed 0.5-, 0.5-, 2- and 2-fold 
changes, respectively). In contrast, T and BLIMP1 expression levels were rapidly 
upregulated within the first 2 days (512- and 32-fold changes, respectively) and 
gradually downregulated thereafter. Interestingly, the induction of T expression 
occurred one day earlier than that of BLIMP1. T expression started on day 1 and 
BLIMP1 expression on day 2, results that were confirmed by immunostaining (Fig. 
12B). Furthermore, BLIMP1 co-localized with OCT4. These results are consistent 
with observations in mouse studies, suggesting that gene expression dynamics during 
the induction of PGC precursors are developmentally conserved between the human 
and mouse species. 
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Figure 12 Time course analysis of PGC precursor induction. (A) Gene expression dynamics of 
selected pluripotency, PGC, and mesodermal genes during prolonged PGC-precursor induction up to 
day 7. Samples were calibrated with iPSC values, and iPSC values depict 1. Y-axes are in log2 scale. 
(B) Immunofluorescence analysis of OCT4, BLIMP1 and T on days 0, 1, and 2. The culture contained 
BMP4 (5 ng/ml), ActA (50 ng/ml), and bFGF (20 ng/ml) (also in E and F). Scale bar: 100 µm. 
Surprisingly, OCT4 and BLIMP1 were still expressed at intermediate levels on day 7, 
implying that mesoderm-committed PGC precursors were still present at later time 
points of the differentiation. However, immunofluorescence analysis revealed that 
OCT4 and BLIPM1 no longer co-localized, indicating the loss of mesoderm-
committed PGC precursors during prolonged culture in vitro (Fig. 13A). Overall, 
differentiation under defined conditions (N2B27 +ActA +BMP4 +bFGF) for 2 days is 
sufficient for the generation of mesoderm-committed PGC precursors. However, upon 
longer culture, the precursors lose their identity, become unstable and undergo further 
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differentiation into other cell lineages. Of special note is that, I did not detect c-KIT 
protein levels in OCT4+ cells, although the c-KIT transcript level was significantly 
upregulated until day 7 (Fig. 13B), This result indicates that the PGC precursors do 
not develop into lineage-restricted PGCs under the given culture conditions, but 
require another appropriate environment to become PGC-like cells.  
 
 
 
Figure 13 Immunofluorescence analysis of PGC precursor cultures. (A) Immunofluorescence analysis 
of OCT4 and BLIMP1 on day 5 of germ cell precursor induction. Scale bar: 20 µm. (B) 
Immunofluorescence analysis of OCT4 and c-KIT on the day of germ cell precursor induction. Scale 
bar: 20 µm. 
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3.1.6.Differentiation of PGC precursors towards PGC-like cells  
To obtain PGC-like cells, I cultured the precursors in GK20 containing BMP4 for 
another 7 days to induce further differentiation (Fig. 14A). I observed an initial 
population of GFP+ cells on day 6 and found a continuous increase in the number of 
GFP+ cells until day 9 (14B).  
 
Figure 14 Induction of PGC-like cells from human iPSCs. (A) Schematic presentation of PGC-
precursor and PGC-like cell induction. (B) Time-course images of PGC-like cell induction from days 6 
to 9 of differentiation. Phase contrast and GFP fluorescent images are shown. Scale bar: 100 µm. 
Then I attempted to isolate theses cells by FACS, but failed to do so due to unknown 
technical problems. For thi I chose an alternative approach. A previous study 
demonstrated that TRA-1-81+/c-KIT+ populations represent post-migratory putative 
germ cells in humans (Gkountela et al, 2013). I utilized this approach and sorted germ 
cell populations by FACS. Indeed, GFP was highly enriched in both TRA-1-81+/c-
KIT+ and TRA-1-81-/c-KIT+ cells, whereas c-KIT- cells, regardless of TRA-1-81 
expression, did not express GFP (Fig. 15). Thus, TRA-1-81 and c-KIT are reliable 
markers for isolating STELLA+ cells and can be used in support of the reporter 
system.  
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Figure 15 GFP expression of each cell fraction sorted by TRA-1-81 and c-KIT of cells from the 
aggregate cultures. 
Next I titrated for the optimal concentration of BMP4 required for the transition of the 
precursors toward PGC-like cells. I observed that the number of TRA-1-81+/c-KIT+ 
cells increased in a dose-dependent manner (from 15.6% to 24%) (Fig. 16A) with an 
optimal BMP4 concentration of 100 ng/ml. Notably, in the absence of BMP4, we 
observed that approximately 7% of the cells were TRA-1-81+/c-KIT+, which most 
probably represented PGC-committed cells, as there was 5 ng/ml of BMP4 in the 
precursor induction medium. Interestingly, the maximum number of TRA-1-81+/c-
KIT+ cells (>20%) was observed on day 4 (Fig. 16B). Thereafter the number of TRA-
1-81+/c-KIT+ cells started to decrease, with a significant decrease observed on day 6 
and only 2.2% of such cells observed on day 8. 
 
Figure 16 Induction of TRA-1-81+/c-KIT+ PGC-like cells from human iPSCs. (A) FACS analysis of 
the concentration-dependent effect of BMP4 on TRA-1-81+/c-KIT+ PGC-like cells on day 4. B25: 25 
ng/ml BMP4; B50: 50 ng/ml BMP4; B100: 100 ng/ml BMP4. All conditions contained human LIF (20 
ng/ml). (B) FACS analysis of TRA-1-81 and c-KIT during PGC induction up to day 8. 
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To overcome this loss of PGC-like cells I added SCF to the medium, but this 
approach was not successful (Fig. 17A). Nonetheless, differentiation of the precursors 
led to the reproducible induction of a sufficient number of PGC-like cells from 
independent cell lines (Fig. 17B).  
 
 
 
Figure 17 Effect of SCF on the induction of TRA-1-81+/c-KIT+ PGC-like cells. (A) Effect of SCF 
during PGC-like cell induction on PGC- like cell survival of d6 cultures. (B) Induction of PGC-like 
cells from the HuES6 ESCs and SA8 iPSCs on day 4. 
3.1.7.Characterization of PCG-like cells 
Next, I characterized the isolated PGC-like cells (TRA-1-81+/c-KIT+ cells) in more 
detail. First, I evaluated the gene expression profiles of key markers (OCT4, NANOG, 
SOX2, BLIMP1, and STELLA) (Fig. 18A). In contrast to the c-KIT- populations, 
BLIMP1 and STELLA expression levels were dramatically upregulated in PGC-like 
cells, whereas OCT4 and NANOG levels remained similar to iPSC levels. 
Upregulation of BLIMP1 expression began on day 4 of differentiation, but that of 
STELLA expression only on day 6. Immunofluorescence analysis confirmed that 
endogenous OCT4, BLIMP1, and STELLA proteins were enriched in PGC-like cells 
(Fig. 18B). Interestingly, SOX2 was downregulated in PGC-like cells, consistent with 
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the known low SOX2 expression level in human PGCs. This finding strongly 
suggested that these cells represent in vitro counterparts of natural human PGCs.  
 
 
 
Figure 18 Characterization of PGC-like cells. (A) Gene expression dynamics of selected pluripotency 
and PGC genes in FACS-sorted, specified cells during PGC induction. The value for iPSCs is set as 1, 
and values are on log2 scale. (B) Immunofluorescence staining of TRA-1-81+/c-KIT+ PGC-like cells. 
Scale bar: 20 µm. 
During PGC development, epigenetic reprogramming occurs globally and in a locus-
specific manner (Gkountela et al, 2013; Kagiwada et al, 2013; Seki et al, 2007). 
Therefore, I next assessed the erasure of DNA methylation at regulatory regions of 
imprinted loci and globally in PGC-like cells. PEG1, KvDMR1, PEG10, and NESP55 
were differentially methylated in both maternal and paternal alleles of iPSCs, but 
most became demethylated in PGC-like cells (Fig. 19A). Furthermore, examination of 
global DNA methylation levels by immunofluorescence against 5mC provided strong 
evidence that DNA methylation was globally erased in PGC-like cells (Fig. 19B). 
Taken together, the reduced level of methylation at imprinted loci and the loss of 
methyl-cytosines in the genome indicate the progress of global epigenetic 
reprogramming in PGC-like cells similarly to that in PGCs in vivo. 
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Figure 19 Epigenetic state of PGC-like cells. (A) Bisulfite sequence analysis of DMRs of the 
imprinted genes (PEG1, KvDMR1, PEG10, and NESP55) in iPSCs (top) and TRA-1-81+/c-KIT+ 
PGC-like cells (bottom). White and black circles represent unmethylated and methylated CpG 
sequences, respectively. (B) Immunofluorescence analysis of 5mC in iPSCs and TRA-1-81+/c-KIT+ 
PGC-like cells. Scale bar: 20 µm 
I then evaluated the developmental potential of the PGC-like cells. PGCs are known 
to be bipotent, as they develop only into sperm and oocytes in vivo. To assess the cells’ 
potential, I performed reconstituted ovary transplantation. PGC-like cells or iPSCs 
were aggregated with 12.5-dpc mouse embryonic gonadal somatic cells to form 
reconstituted ovaries in vitro, which were then transplanted under the ovarian bursa of 
female mice. After 3 months teratomas had formed from the reconstituted ovaries 
generated from iPSCs (n=2) (Fig. 20(i)). Importantly, I did not observe any teratomas 
from reconstituted ovaries with PGC-like cells, indicating that those cells are not 
pluripotent (n=10) (Fig. 20(ii)). However, I also did not observe mature PGC-like 
cells, which can be attributed to a likely non-permissive environmental niche.  
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Figure 20 Teratoma formed from iPSCs and PGC-like cells 3 months after transplantation. (i) left 
ovary: control ovary without transplantation; right ovary: transplanted with iPSC-reconstituted ovary; 
(ii) ovaries transplanted with PGC-like cell-reconstituted ovaries. 
 
 
3.1.8. The molecular mechanism of PGC induction in vitro 
Knockout serum replacement (KSR) is known to enhance differentiation of cells into 
PGC-like cells in mice by suppressing cell death during the transition of ESCs into 
epiblast-like cells, which then further differentiate to generate PGCLCs (Hayashi et al, 
2011). WNT3A is expressed in the mouse posterior epiblast, plays a crucial role in 
PGC specification (Aramaki et al, 2013; Ohinata et al, 2009) and enhances the 
differentiation of human ESCs into human PGCs in the presence of serum (Chuang et 
al, 2012). I therefore investigated whether KSR and WNT3A would also similarly 
affect PGC-like cell induction in our system. To assess the influence of KSR, I added 
KSR to the PGC precursor medium at a concentration of 0–20% and assessed the 
expression of OCT4, NANOG, SOX2, T, BLIMP1, and STELLA on day 2 (Fig. 21A). 
OCT4 and NANOG expression levels were similar independent of the KSR 
concentration, whereas the SOX2 expression level was strongly upregulated to iPSC 
level in a concentration-dependent manner. T expression levels were similar in KSR 
concentration between 0% and 4%, but decreased dramatically in 10–20%. BLIMP1 
expression gradually decreased in a concentration-dependent manner. Importantly, 
STELLA expression was not affected by the KSR concentration, indicating that KSR 
does not enhance the induction of the PGC-like cell state. Taken together, the study 
showed that KSR suppressed the differentiation of ESCs into mesodermal cells by 
maintaining their ESC-specific gene expression profile. To assess the PGC induction 
ability of the cells that had been differentiated with different KSR concentrations, I 
allowed them to further differentiate in PGC medium. TRA-1-81+/c-KIT+ PGC-like 
cells were induced under 0–2% KSR conditions, but not under 4%KSR condition (Fig. 
21B). Of note, TRA-1-81+/c-KIT+ cells induced under 10 and 20% KSR conditions 
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lack BLIMP1 expression, which is major PGC determinant, indicating these cells are 
not PGC-like cells. Based on these data, it seems clear that a high concentration of 
KSR inhibits the induction of PGC precursors by suppressing mesodermal gene 
activation. 
 
To address the effect of WNT3A, I added 100 ng/ml of WNT3A to the PGC-
precursor medium together with 0–20% KSR and assessed gene expression on day 2 
(Fig. 21A). WNT3A did not drastically alter the gene expression patterns, as all genes 
investigated exhibited relatively similar levels and changes in expression in the 
presence or absence of WNT3A. Nevertheless, T and BLIMP1 expression seemed 
slightly enhanced by WNT3A. T expression levels were lower in the presence of 
WNT3A under low KSR conditions (0–4%). However, T expression was not sharply 
downregulated, and levels thus remained intermediate under high KSR conditions 
(10–20%). BLIMP1 expression levels were slightly enhanced in the presence of 
WNT3A and, interestingly, were more slowly reduced by increasing KSR 
concentrations. Thus, WNT3A does not enhance differentiation toward the 
mesodermal cell state in our system, but exhibits an antagonistic effect on the 
repression of mesodermal genes by KSR. I then looked at the efficiency of PGC-like 
cell induction from each culture. Similarly to the cultures lacking WNT3A, PGC-like 
cells could be induced from cells grown under low KSR conditions, but not from the 
cells grown under high KSR conditions (Fig. 21B). These data indicate that WNT3A 
does not significantly enhance the induction of PGC precursors. I therefore concluded 
that KSR and WNT3A do not enhance the induction of PGC precursors or PGC-like 
cells in our system. KSR actually had an inhibitory effect. 
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Figure 21 Effects of KSR and WNT3A during PGC-precursor induction. (A) Gene expression analysis 
of selected pluripotency, PGC, and mesodermal genes of d2 cultures. The value for iPSCs is set as 1, 
and values are on log2 scale. (B) The induction of PGC- like cells as analyzed by FACS gated for 
TRA-1-81 and c-KIT. 
Nevertheless, PGC-like cells were still induced in medium containing 4% KSR with 
WNT3A, which was not seen in medium containing 4% KSR without WNT3A (Fig. 
21B). This finding indicated that the two culture conditions possess distinct abilities 
to induce PGC-like cells. Of all the genes investigated, including ecto-/meso-
/endoderm markers, the expression of only BLIMP1 was significantly different in 
those cultures (Fig. 21A and 22). Specifically, BLIMP1 mRNA levels increased in 
medium containing 0%, 1%, and 2% KSR in the absence or presence of WNT3A, but 
increased in medium containing 4% KSR only in the presence of WNT3A. We 
therefore hypothesized that the expression of BLIMP1 during PGC-precursor 
induction might be crucial for further PGC induction, similarly to the role of Blimp1 
in mouse PGC specification.  
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Figure 22 Effects of KSR and WNT3A during PGC-precursor induction on the expression of selected 
trophecto-, ecto-, endo-, and mesodermal genes of d2 cultures. 
To evaluate our hypothesis, I performed immunofluorescence analysis for BLIMP1, 
together with OCT4 and T (Fig. 23A). In accordance with the qPCR results, I 
observed that the majority of cells were OCT4+ under all culture conditions, whereas 
T+ cells were strongly induced only under low KSR conditions. BLIMP1+ cells were 
significantly induced under both low and high KSR conditions. However, the 
BLIMP1+ cells under high KSR conditions did not co-express OCT4 and apparently 
committed to other cell lineages. Statistical cell counts demonstrated that the 
percentage of OCT4+ cells was the same under all conditions, while that of BLIMP1+ 
cells modestly decreased in a KSR concentration–dependent manner. Importantly, the 
number of OCT4+/BLIMP1+ cells within the total BLIMP1+ cell population 
decreased significantly in a KSR concentration–dependent manner, reaching zero 
under high KSR conditions (Fig. 23B). These data clearly demonstrate that 
OCT4+/T+/BLIMP1+ cells indeed represent PGC precursors that subsequently 
commit to become PGCs, paralleling previously published data on mouse PGC 
specification (Saitou et al, 2002).  
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Figure 23 Effects of KSR and WNT3A on PGC-precursor and PGC-like cell induction. (A) 
Immunofluorescence analysis of OCT4, BLIMP1, and T on day 2 and STELLA- GFP on day 8. (B) 
Statistical cell counting of d2 cultures. Pictures were captured at different locations on the cell culture 
plates and analyzed. 
3.1.9.Global gene expression analysis of PGC precursors and PGC-like cells 
To further characterize day-2 (d2) PGC-precursor cultures and day-4 (d4) and day-6 
(d6) PGC-like cells, I assessed their global transcription profiles (Fig. 24A). 
Unsupervised hierarchical clustering (UHC) revealed that d2 PGC-precursor cultures 
clustered together with iPSCs, whereas d4 and d6 PGC-like cells clustered together, 
but separately from d2 precursors and iPSCs (Fig. 24B). Principal component analysis 
(PCA) also showed a distinct difference between iPSCs or d2 PGC-precursor cells 
and d4 or d6 PGC-like cells (Fig. 24C). These data indicate that PGC-like cells 
acquired a distinct global transcription profile and therefore a different cell identity 
compared with iPSCs. Scatter plot analysis comparing either d2 PGC-precursor 
culture, or d4 or d6 PGC-like cells with iPSCs revealed that OCT4 and NANOG 
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expression levels were similar to those of iPSCs in all differentiated samples and that 
SOX2 levels were strongly downregulated in PGC-like cells. These results were 
validated by qPCR analysis (Fig. 18A). Expression levels of mesodermal genes (such 
as CYP26A1, GSC, MESP, and MIXL1) were upregulated in d2 PGC precursors and 
thereafter progressively downregulated in d4 and d6 PGC-like cells. Expression levels 
of PGC genes (such as STELLA, NANOS3, and TFAP2C) did not change in d2 PGC 
precursors and d4 PGC-like cells, but significantly increased in d6 PGC-like cells, 
indicating the formation of lineage-restricted PGCs on day 6. The subsequent 
expression of mesodermal genes and PGC genes in our differentiation system is 
overall similar to the transcription dynamics observed during mouse PGC 
specification, with the exception of SOX2 expression, which is drastically different.  
 
 
 
Figure 24 Global transcription profiles during PGC-precursor and PGC-like cell induction. (A) Heat 
map of global gene expression patterns of HuES6 ESCs, 383.2iPSCs, d2 PGC-precursor cultures, and 
FACS-sorted PGC-like cells. The color bar at top codifies the gene expression in log2 scale. Red and 
blue colors indicate high and low gene expression, respectively. (B) Unsupervised hierarchical 
clustering (UHC) of HuES6 ESCs, 383.2iPSCs, d2 PGC-precursor cultures, and FACS-sorted PGC-
like cells. (C) Principal component analysis of HuES6 ESCs, 393.2 iPSCs, d2 PGC-precursor cultures, 
and FACS-sorted PGC-like cells. (D) Scatter plots of global gene expression microarrays comparing d2 
PGC-precursor cultures, or d4 or d6 FACS-sorted PGC-like cells with iPSCs. 
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In addition to the expression of representative key markers, I analyzed the extent of 
shared gene dynamics between human PGC-like cell induction and mouse PGC 
specification. A recent mouse study identified two categories of genes that are 
activated during PGC specification. One category is the “somatic mesodermal genes,” 
which are activated by BMP4 and eventually suppressed upon formation of lineage-
restricted PGCs, and the other is the “core PGC genes,” which are specifically 
activated by Blimp1, Prdm14, and Tfap2c (Nakaki et al, 2013). I therefore examined 
the expression profiles of the genes from each category to assess whether similar 
transcriptional changes occur during human PGC-like cell induction (Figure 25). Of 
the 159 somatic mesodermal genes examined, 30 were upregulated (>2 fold) in d2 
precursor cells, including CDX1, CDX2, HAND1, MESP1, ID1, MSX1, MSX2, ISL1, 
MIXL1, WNT5A, FGF8, and BMP4. The number of genes that were upregulated 
increased to 50 on day 4 and 65 on day 6. 
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Figure 25 (Continued) 
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Figure 25 (continued)  
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Figure 25 Heat map of somatic mesodermal gene expression patterns of HuES6 ESCs, 383.2iPSCs, d2 
PGC-precursor cultures, and FACS-sorted PGC-like cells. The color bar at top codifies the gene 
expression in log2 scale. Red and blue colors indicate high and low gene expression, respectively. 
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Of the core PGC genes, I found that 22 of 45 genes were upregulated (>2fold) in d6 
PGC-like cells, including TFAP2C, STELLA, KLF2, ELF3, KIT, and LIFR (Figure 26). 
Thus, the expression of somatic mesodermal genes and core PGC genes during human 
PGC-like cell induction was similar to that during mouse PGC specification. Taken 
together, these data reveal that human and mouse PGC-like cell induction share 
expression patterns of not only a few key markers, but also larger sets of genes within 
different functional categories. 
 
 
Figure 26 Heat map of core PGC mesodermal gene expression patterns of HuES6 ESCs, 383.2iPSCs, 
d2 PGC-precursor cultures, and FACS-sorted PGC-like cells. The color bar at top codifies the gene 
expression in log2 scale. Red and blue colors indicate high and low gene expression, respectively. 
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Interestingly, I identified some epigenetic modifiers, such as the TET family genes, 
with similar expression levels in PGC-like cells as in ESCs, but downregulated 
DNMT1 and DNMT3B levels (Fig. 27). This indicated that the reduction of 5mC 
levels might involve passive mechanisms by replication-coupled dilution, similarly to 
mouse PGCs, thus confirming the notion that key epigenetic features are indeed 
shared between human PGC-like cell induction and mouse PGC specification.  
 
 
 
Figure 27 Array expression data for selected epigenetic modifier genes in 383.2 iPSCs, d2 PGC-
precursor cultures, and FACS-sorted PGC-like cells.  
Surprisingly, I observed that PRDM14 expression was strongly downregulated in 
PGC-like cells (Fig. 24D). In mice, Prdm14 is known to function as a key regulator of 
PGC specification and the lack of Prdm14 leads to loss of PGCs (Yamaji et al, 2008). 
I therefore assessed whether the lack of PRDM14 in our PGC-like cells influences the 
expression of particular genes activated during mouse PGC specification.  
 
A recent mouse study reported sets of genes that are regulated through the action of 
Prdm14 (genes upregulated are Epas1, Tcl1, Esrrb, Klk5, Nr5a2, ZFfp42, Klf4, Lifr, 
Dppa2, Dppa5a, and Nanog; genes downregulated are Zfp521 [human homolog: 
ZNF521], Sox3, Nrcam, and Hs6st2) (Nakaki et al, 2013). I first looked at the 
expression profile of these genes in human PGC-like cells (Figure 28). EPAS1, KLF5, 
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KLF4, and LIFR expression levels were upregulated (>2 fold) in PGC-like cells, 
whereas ZFP42 and NANOG levels did not change and were as high as iPSC levels. 
On the other hand, TCL1A, ESRRB, NR5A2, DPPA2, and DPPA5 levels were low. 
ZNF521, SOX3, and NRCAM expression levels were downregulated (>2 fold), while 
the HS6ST2 level was upregulated in human PGC-like cells. These data clearly 
demonstrate that a subset of mouse Prdm14-regulated genes exhibits a similar 
expression pattern in human PGC-like cells, even though PRDM14 is expressed at 
only very low levels.  
 
 
 
Figure 28 Heat map of mouse Prdm14-regulated genes in HuES6 ESCs, 383.2 iPSCs, d2 PGC-
precursor cultures, and d4 and d6 FACS- sorted PGC-like cells. The color bar at top codifies the gene 
expression in log2 scale. Red and blue colors indicate high and low gene expression, respectively. 
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In addition, gene set enrichment analysis (GSEA) revealed that genes associated with 
neural development were significantly downregulated in PGC-like cells (Table 4). 
The repression of neural differentiation genes is a key characteristic of mouse PGC 
specification that is mediated by Prdm14. This finding confirms that human PGC-like 
cell induction exhibits similar transcriptional dynamics to mouse PGC specification, 
and suggests that mouse Prdm14-regulated genes are actually regulated by other 
mechanisms in human PGCs. 
 
 
Table 4 List of significant enriched gene sets between iPSCs and d6 FACS-sorted PGC-like cells from 
GSEA. 
 
Downregulated gene sets in d6 PGC-like cells 
Gene set P value 
Central nervous system development 1,11E-04 
Nervous system development 1,45E-04 
Multicellular organismal development 2,76E-04 
Neurological system process 1,70E-03 
Transforming growth factor beta receptor signaling pathway 2,30E-03 
Enzyme linked receptor protein signaling pathway 3,14E-03 
Anatomical structure development 4,22E-03 
Transcription factor activity 6,53E-03 
Synaptic transmission 1,85E-02 
Sensory reception 2,29E-02 
Anatomical structure morphogenesis 3,98E-02 
  
Upregulated gene sets in d6 PGC-like cells 
Gene set P value 
Extracellular region 1,15E-08 
Extracellular region part 3,34E-08 
Extracellular region space 4,55E-08 
Lipid transport 1,40E-05 
Digestion 1,77E-05 
Hormone metabolic process 1,97E-04 
Lipid metabolic process 2,24E-04 
Steroid metabolic process 2,26E-04 
Enzyme activator activity 4,43E-04 
Lipid homeostasis 4,86E-04 
Steroid binding 6,29E-04 
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Table 4 (continued) 
 
 
Negative regulation of secretion 8,56E-04 
Chemical homeostasis 1,12E-03 
Cell surface receptor linked signal transduction GO 0007166 2,02E-03 
Lipid transporter activity 2,06E-03 
Cofactor transport 3,02E-03 
Receptor activity 3,11E-03 
Female pregnancy 3,25E-03 
Collagen binding 4,06E-03 
Transition metal ion transmembrane transporter activity 4,32E-03 
Phospholipase activity 4,26E-03 
G protein coupled receptor protein signaling pathway 4,32E-03 
Lyase activity 4,88E-03 
Metal ion transport 5,29E-03 
CDC42 protein signal transduction 5,35E-03 
Transmembrane receptor activity 6,41E-03 
Reproductive process 6,64E-03 
Hormone binding 6,76E-03 
Cellular lipid metabolic process 7,00E-03 
Ras protein signal transduction 7,82E-03 
Myosin complex 8,35E-03 
Lipid binding 9,64E-03 
Myoblast differentiation 1,01E-02 
 
 
With the unavailability of human in vivo pre-migratory PGC samples and global 
transcription data of those cells, we compared data from our PGC-like cells and iPSCs 
with published data sets from Gkountela et al and Nakaki et al (Gkountela et al, 2013; 
Nakaki et al, 2013). We performed comparative gene expression analysis and 
identified 6 and 10 genes that were commonly down- or upregulated, respectively, in 
PGC-like cells, in vivo post-migratory PGCs, and mouse in vitro–generated PGCs 
compared with the corresponding human ESC lines and mouse EpiLCs (Fig. 29-33). 
Of these, DNMT3B was downregulated, indicating suppression of de novo DNA 
methylation, which is a common event at the early stage of PGC development in 
humans and mice. BLIMP1, STELLA, and KLF2 expression was upregulated; 
however, SOX2 and PRDM14 expression was downregulated in human PGCs and 
PGC-like cells, but not in mouse in vitro–generated PGCs. Of note, human PGC-like 
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cells exhibited similar LIFR expression levels as mouse PGCs, indicating that our 
cells shifted from a FGF-dependent state to an LIF-dependent state to activate 
pluripotency genes. These observations suggested that the lack of PRDM14 is a 
characteristic unique to human PGCs, and that human PGCs lack the expression of 
PRDM14 from their early commitment to the germ lineage until at least the post-
migratory stage.  
 
Figure 29 Venn diagrams of intersection between mouse in vitro PGCLCs, human in vivo PGCs, and 
human in vitro PGC-like cells. 
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Figure 30 Heat map of genes commonly downregulated in human PGC-like cells and mouse PGC-like 
cells. The color bar at top codifies the gene expression in log2 scale. Red and blue colors indicate high 
and low gene expression, respectively. 
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Figure 31 Heat map of genes commonly upregulated in human PGC-like cell and mouse PGC-like. 
The color bar at top codifies the gene expression in log2 scale. Red and blue colors indicate high and 
low gene expression, respectively. 
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Figure 32 Heat map of genes commonly downregulated in human PGC-like cells and 16-16.5 week 
PGCs. The color bar at top codifies the gene expression in log2 scale. Red and blue colors indicate high 
and low gene expression, respectively. 
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Figure 33 Heat map of genes commonly upregulated in human PGC-like cells and 16-16.5 week PGCs. 
The color bar at top codifies the gene expression in log2 scale. Red and blue colors indicate high and 
low gene expression, respectively. 
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Our data indicated that the expression of BLIMP1 is associated with PGC 
commitment from human iPSCs, whereas PRDM14 is not. To determine this thought, 
I transduced iPSCs with lentiviral vectors producing small hairpin RNA (shRNA) 
against BLIMP1 and PRDM14. The expression level of BLIMP1 or PRDM14 was 
impaired in BLIMP1- or PRDM14-shRNA-transduced cells, respectively (Fig. 34A). 
As shown in Figure 34B, the knock-down of BLIMP1 lead to impaired induction of 
TRA-1-81+/c-KIT+ PGC-like cells on day 4 (ca. 50%). In contrast, the knock-down 
of PRDM14 did not affect the induction efficiency (ca. 100%). This data clearly 
indicated that BLIMP1 plays an important role in human PGC commitment, whereas 
PRDM14 has less or no impact on it. 
 
 
 
Figure 34 Knock-down of BLIMP1 and PRDM14 (A) Knock-down efficiency of shRNAs in human 
ESCs after 2 days of infection. (B) The induction efficiency of TRA-1-81+/c-KIT+ PGC-like cells on 
day4. 
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3.2. PGC differentiation from mouse EpiSCs and ΔPE-Oct4-GFP+ EpiSCs 
3.2.1. PGC differentiation from mouse EpiSCs 
I could demonstrate that our in vitro system successfully generated PGC- and oocyte-
like cells from mouse ESCs by molecular and ultrastructure analyses (section 4.2). I 
hypothesized that this differentiation system would also be able to induce PGCs from 
mouse epiblast stem cells (EpiSCs). EpiSCs are pluripotent stem cells derived from 
post-implantation embryo (Brons et al, 2007; Tesar et al, 2007). Although EpiSCs 
share some common properties with ESCs, such as expression of key pluripotency-
associated genes including Oct4, Nanog and Sox2, they are significantly different in 
their epigenetic state and gene transcription profile (Brons et al, 2007; Guo et al, 
2009; Hayashi et al, 2008; Tesar et al, 2007). In particular, EpiSCs are derived from 
epiblast cells from which PGCs originate in vivo. Therefore, the differentiation of 
PGCs from EpiSCs could provide a better platform for an investigation on PGC 
specification. Furthermore, EpiSCs share some properties with human ESCs, such as 
flattened colony morphology and the culture conditions for maintainance, giving rise 
to the idea that establishment of a PGC induction protocol from mouse EpiSCs could 
be instrumental toward the establishment of differentiation systems with human 
pluripotent stem cells. 
 
Mouse GOF18-EpiSCs that contain a GFP transgene under the control of the entire 
regulatory region of the Oct4 gene (Yeom et al, 1996) were differentiated with a 
modified protocol to PGCs (Fig. 35A). As shown in Figure 35B, strong GFP signal 
was observed in differentiated EBs after 7 days of differentiation. FACS analysis 
revealed that 73.9% of the cells are Oct4-GFP+ and, furthermore, 36.8% of cells 
exhibit both Oct4-GFP and c-KIT expression, characteristic of in vivo PGCs (Fig. 
35C). This result indicated that this differentiation protocol efficiently induces OCT4-
GFP+/c-KIT+ putative PGCs from mouse EpiSCs. I then analyzed the gene 
expression level of key genes, Oct4, Sox2, Nanog, Blimp1, Prdm14, Stella, Dazl and 
Vasa in Oct4-GFP+/c-KIT+ PGC-like population. As shown in Figure 35D, 
pluripotency-associated genes, Oct4, Nanog and Sox2, as well as early PGC gene, 
Blimp1, were expressed in the PGC-like population at a similar level to EpiSCs. In 
contrast, the early PGC genes Prdm14 and Stella were highly upregulated in the PGC-
like population (16-fold and 156-fold, respectively). Furthermore, the late PGC genes 
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Dazl and Vasa were also highly upregulated (128-fold and 512-fold, respectively), 
indicating their progress to the post-migratory stage. In fact, SYCP3 staining by 
immunofluorescence analysis exhibited a premeiotic staining pattern, indicating that 
cells prepared to enter meiosis (Fig. 35D). These results suggested that this 
differentiation protocol induces presumptive PGCs and that the employed protocol 
apparently worked for EpiSCs. 
 
 
 
Figure 35 Differentiation of mouse EpiSCs toward PGCs. (A) Scheme of PGC differentiation. (B) 
Oct4-GFP expression on day 7 of differentiation. Phase contrast and GFP fluorescence images are 
shown. (C) FACS analysis of the differentiated cells on day 7. (D) Gene expression analysis of Oct4-
GFP+/c-KIT+ cells. The value for EpiSCs is set as 1, and values are on log2 scale. (E) 
Immunofluorescent analysis of SYCP3 in Oct4-GFP+/c-KIT+ cells. 
However, although I obtained this result from my first attempt, I failed to reproduce it 
later (n=3). Upon differentiation, I regularly obtained similar ratios of Oct4-GFP- and 
Oct4-GFP+ cells, but I did not observe c-KIT expression anymore (ca. 0.4%) (Fig. 
36). This might be attributed to undefined changes of components in MEF-
conditioned medium (MEF-CM), which were used for both maintenance and 
differentiation of EpiSCs. MEF-CM has batch differences depending on the MEF 
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preparation (see discussion for details). If culturing EpiSCs in defined culture 
condition resolves this problem has to be elucidated by further investigations. 
 
 
 
Figure 36 FACS analysis of the day7 differentiated EpiSCs by GFP and c-KIT 
3.2.2. PGC differentiation from mouse PE-Oct4-GFP+ EpiSCs
The competence of the epiblast for the germ cell fate is restricted between E5.5 and 
E6.25, as PGC-like cell are induced only from E5.5-6.25 epiblast, but not from the 
epiblast later than E6.5 (Ohinata et al, 2009). Interestingly, one of our recent studies 
demonstrated that EpiSCs have two distinct populations distinguished by PE-Oct4-
GFP expression (Han et al, 2010). Oct4 contains a proximal (PE) and a distal (DE) 
enhancer element, which are preferentially used in EpiSCs or ESCs and PGCs, 
respectively. The study by Han et al. demonstrated that the PE-Oct4-GFP negative 
population in EpiSCs represents cells of the E6.5 postgastrulation embryo, while the 
PE-Oct4-GFP positive population represents cells of the E5.5 pregastrulation 
embryo. Based on this, I hypothesized that the Oct4-GFP+ cells in EpiSCs posess a 
higher competence for the germ cell fate.  
 
Mouse  PE-Oct4-GFP+ EpiSCs (named stabilized EpiSCs, Fig 37A) were 
differentiated using the modified differentiation protocol to PGCs. As shown in 
Figure 37B, strong GFP signal was observed in differentiated EBs on day 7 of the 
differentiation. However, FACS analysis revealed that only a small population of 
these GFP+ cells expressed c-KIT (1.2%, Fig. 7C), indicating that our differentiation 
protocol insufficiently induces putative PGCs from stabilized EpiSCs. Interestingly, I 
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observed the induction of Oct4-GFP+/SSEA-1+ cells (37.1%), which is another 
marker for PGCs in vivo (Fig. 7D). Gene expression analysis was performed for Oct4, 
Sox2, Nanog, Prdm14, Stella, Dazl and Vasa and to our surprise observed that many 
PGC genes, such as Bimp1, Prdm14, Stella, Dazl and Vasa were significantly 
upregulated, independent from SSEA-1 expression, while Oct4, Nanog and Sox2 
retained similar expression levels to those in EpiSCs (Fig. 7E). Since c-KIT is one of 
the definitive markers for PGCs, these cells cannot be considered PGCs per se. The 
detailed character of these Oct4-GFP+/SSEA-1+ cells and how PGC genes are 
upregulated in these cells at present is unclear. Based on the results, we concluded 
that our mouse PGC system needs to be optimized to induce PGC-like cells from 
stabilized EpiSCs. 
 
 
Figure 37 Differentiation of mouse PE-Oct4-GFP+ EpiSCs toward PGCs. (A) Oct4-GFP expression 
in undifferentiated cells. Phase contrast and GFP fluorescence images are shown. Scale bar: 20 µm. (B) 
Oct4-GFP expression on day 7 of differentiation. Phase contrast and GFP fluorescence images are 
shown. Scale bar: 20 µm. (C) FACS analysis of the day 7 differentiated cells by GFP and c-KIT. (D) 
FACS analysis of the day 7 differentiated cells by GFP and SSEA-1. (E) Gene expression analysis of 
Oct4-GFP+/SSEA-1+ cell. The value for EpiSCs is set as 1, and values are on log2 scale. 
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3.3. Ultrastructural characterization of mouse embryonic stem cell-derived 
oocytes and granulosa cells 
8.3.1. Granulosa cells and the GC–oocyte interface of ESC-derived follicles 
The entry of PGCs into meiosis in vivo and in vitro appears to be a cell autonomous 
process. Subsequent development of PGCs into competent oocytes and ultimate 
meiotic arrest during folliculogenesis is dependent on 2-way signaling interactions 
between the oocyte and surrounding granulosa cells (Adams & McLaren, 2002; 
Gosden et al, 2002). Figure 38A–D shows ESC-derived follicle-like structures. As 
aggregation of PGCs and granulosa-like cells takes place randomly in this system, we 
obtained spherical aggregates with centrally located single as well as multiple putative 
germ cells surrounded by various layers of attached presumptive granulosa cells and 
ECM. Light microscopy revealed germ cell clusters surrounded by loosely attached 
somatic granulosa-like cells (Fig. 38A). Scanning electron microscope (SEM) 
analysis demonstrated follicle-like structures, that is, germ cells surrounded by a 
dense layer of cuboidal cells (Fig. 38B). Figure 1C shows ESC-derived putative 
granulosa cells in direct proximity to a zona pellucida-like matrix. The granulosa-like 
cells exhibit a polygonal shape and a smooth surface with few microvilli (Fig. 38C). 
SEM and transmission electron microscopy (TEM) analysis revealed a structure 
specific for granulosa cells, that is, TZPs (Fig. 38C, 38D, arrow) that extend toward 
the putative oocyte. 
 
Figure 39A shows a light microscopy image of an ESC-derived follicular structure, 
with presumptive granulosa cells surrounding the GFP-positive oocyte-like cell. To 
analyze the granulosa cell–oocyte interface by SEM, in vitro-derived follicles were 
cracked. Figure 39C and D shows both parts of a cracked aggregate, revealing their 
morphological similarity to natural follicles. Even though the presumptive oocyte was 
destroyed during the cracking procedure, a round cavity of 50–60 μm in diameter 
with residual oocyte cell material is evident (Fig. 39C, D). Multiple layers of 
granulosa cells surround the cavity. The most central ones exhibiting the typical 
cuboidal-elongated phenotype of natural polarized cumulus cells, that is, those cells in 
direct contact to the oocyte (Fig. 39C), whose TZPs orientate toward the oocyte (Fig. 
39B). TZPs have been well characterized in many mammals by EM (Anderson & 
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Albertini, 1976; Hertig & Adams, 1967), and their number and form have been 
demonstrated to change dynamically during follicular development (Albertini et al, 
2001).  
 
 
 
Figure 38 ESC-derived follicle-like structures. (from Psathaki et al. 2011) (A) Light microscopy image 
of ESC-derived follicle-like structures with clusters of granulosa cells loosely surrounding the oocyte. 
(B) SEM image of a defined follicle structure. Note the layer of densely attached cuboidal cells 
(asterisk). (C) SEM image of polygonal-shaped granulosa cells around a smooth zona pellucida-like 
surface (asterisk). The pole of a granulosa cell is facing toward the oocyte (arrow). (D) TEM image of 
a granulosa cell with an extension stretching towards the oocyte (arrow).  
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To investigate the granulosa cell–oocyte interface in more detail, TEM analyses was 
performed and compared to granulosa cells of natural follicles to ESC-derived 
presumptive granulosa cells. The ultrastructure of TZPs of in vitro-derived granulosa 
cells appeared to be indistinguishable from the TZPs of their natural counterparts, 
indicating generation of the interface between the oocyte and granulosa cells, the 
major control structure for healthy follicle development (Albertini et al, 2001). ESC-
derived granulosa cells of high electron density exhibited long cellular processes 
containing the same dark fine granulation as the cytoplasm (Fig. 2E). These processes 
penetrated the matrix, with some reaching a diameter of ~1 μm, very similar to the 
branched processes of polarized cumulus cell in natural follicles. The detection of 
organelles, for example, mitochondria (Albertini et al, 2001; Zamboni, 1970), within 
the TZPs of in vitro-derived granulosa cells (Fig. 2F, G) is indicative of recapitulation 
of folliculogenesis in vitro. Further, the ultrastructural texture of the pale amorphous 
matrix in direct proximity to the granulosa cells in vitro (Fig. 2E) resembles the zona 
pellucida of the granulosa cell–oocyte interface in vivo (Fig. 2H). 
 
 
 
 
 
 
 
 
 
 
Figure 39 Granulosa cell–oocyte interface of ESC-derived follicles. (from Psathaki et al. 2011) (A) 
Light microscopy image of an ESC-derived follicle structure. Granulosa cells surround the gcOct4-
GFP oocyte. (B) SEM analysis of an ESC-derived follicle-like structure. A long process originates 
from a somatic granulosa cell toward the oocyte (arrow). (C, D) SEM analysis of both halves of a 
cracked ESC-derived follicle-like structure. The position of the oocyte is clearly apparent by the 50–
60-mm-large, round cavity (asterisk in C) and residual oocyte cell material in D (asterisk). The 
granulosa cells surround the oocyte in multiple layers, with the cell layer in direct contact being 
cuboidal-elongated in shape (C, arrow). (E) TEM analysis of ESC-derived granulosa cells. Cells exert 
long processes (TZPs) toward the oocyte (arrow). Note the texture of the pale amorphous matrix 
(asterisk), which is penetrated by the TZPs. (F) TZPs contain organelles such as mitochondria (arrow) 
and have the same ultrastructural texture as the cell cytoplasm. (G) TZPs of ESC-derived granulosa 
cells partly exhibit extreme branching processes (arrow) and reach diameters of almost 1 mm. (H) 
Cellular processes of cumulus cells with branching ends (arrow) of in vivo follicles closely resemble 
those of in vitro-derived granulosa cells. The ultrastructure of the zona pellucida (asterisk) resembles 
that of in vitro-derived follicles in E. 
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Ultrastructural characterization of in vitro-generated granulosa cell-like cells revealed 
additional analogies to characteristics of natural granulosa cells described in the 
literature, for example, the presence of both dark- and light-appearing granulosa cells. 
Dark granulosa cells possess a dark background nucleoplasm and background 
cytoplasm (Fig. 40A, C). The electron density is due to the fine granulation of the 
cytoplasm, which does not correspond to free ribosomes, as free ribosomes would be 
much larger and stand distinctly out from the granular background (Fig. 40E, F). The 
cytoplasm of the granulosa cells appears to be partly vacuolated and is populated by 
mitochondria, ribosomes, and the most prominent organelle of ESC-derived granulosa 
cells, the rough endoplasmic reticulum. Cisternae of swollen rough endoplasmic 
reticulum containing granular material wind through the cytoplasm of dark and light 
in vitro-derived granulosa cells (Fig. 40A, E) as well as pale in vivo granulosa cells 
(Fig. 40F). The ribosomes of natural dark and light granulosa cells and ESC-derived 
granulosa cells are either free or associated with rough endoplasmic reticulum (Fig. 
40A, B, E, F). The presence of free ribosomes is a characteristic feature of protein-
secreting cells, such as the granulosa cells of growing follicles. The mitochondria of 
both dark in vivo and in vitro-derived granulosa cells appear irregular and elongated, 
containing pale cristae and an electron-dense matrix (Fig. 40A, B). The mitochondria 
of light granulosa cells exhibit an oval shape and have tubular–vesicular cristae (Fig. 
40E, F). Lipid droplets filled with a transparent gray substance and empty vacuoles 
frequently surrounded by a membrane (Fig. 40B, D) are distributed throughout the 
cytoplasm of in vivo GCs. Vacuolization appears to be a prominent feature of ESC-
derived granulosa cells (Fig. 40C), manifested mainly by empty white vacuoles and 
vacuoles containing a residual gray substance (Fig. 40C). Empty vacuoles appear to 
be an artifact of sample manipulation, created when the gray substance of lipid 
droplets is washed out during the dehydration step. The nuclei of both in vitro-derived 
and in vivo granulosa cells are large and have an irregular contour (Fig. 40A–D). The 
nucleoplasm of ESC-derived granulosa cells, enclosed by the inner nuclear membrane, 
contains finely dispersed chromatin and clumps of heterochromatin scattered 
throughout (Fig. 40A, C, E); the nucleoplasm of in vivo granulosa cells is arranged 
similarly (Fig. 40B, D, F). Taking these data together, the ultrastructural features of in 
vitro-derived granulosa cells are indistinguishable from natural granulosa cells. Most 
importantly, to the best of my knowledge, there is no other cell in the body capable of 
forming unique and typical TZPs. The observed activated rough endoplasmatic 
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reticulum, indicative for metabolically active and steroid-producing cells, further 
supports their granulosa cell-like identity. 
 
 
Figure 40 (continued) 
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Figure 40 TEM analyses of ESC-derived dark- and light-colored granulosa cells. (from Psathaki et al. 
2011) (A) Cuboidal-elongated in vitro-derived granulosa cells with electron dense cytoplasm and 
swollen rough endoplasmatic reticulum. Mitochondria (insert) exhibit pale tubular cristae. (B) In vivo-
derived dark granulosa cell. Note lipid droplets (asterisk). (C) Dark ESC-derived granulosa cells with 
numerous vacuoles and droplets containing residual gray translucent substance indicative of lipids 
(asterisk). Note prominent nucleolus. (D) In vivo dark granulosa cell with numerous pseudopodia, 
branching processes and protrusions of cytoplasmic invaginations, vacuoles (arrowhead), and lipid 
droplets (asterisk) as detected in in vitro-derived granulosa cell shown in C. (E) ESC-derived light 
granulosa cell with microvilli at the cell surface. The cell exhibits the typical swollen rough 
endoplasmatic reticulum (asterisk) and oval-shaped tubular mitochondria with dark cristae (insert). (F) 
In vivo-derived light granulosa cell with swollen rough endoplasmatic reticulum (asterisk) and 
vesicular–tubular mitochondria (arrow). 
 
 
3.3.2. ESC-derived oocytes 
We have developed a suspension culture system that supports the generation of ESC-
derived oocytes of different follicular stages. Independent of the differentiation media 
used to initiate differentiation of ESCs, we obtained putative oocytes of various 
developmental stages at different yields. Serum-free conditions appeared best to 
promote germ cell differentiation, and XY-ESCs yielded a higher percentage of 
oocytes than XX-ESCs. Expression of specific oocyte marker genes was assessed by 
qPCR in groups of 3 in vitro-derived oocytes and compared with superovulated 
germinal vesicle-stage oocytes and ESCs. As expected, the generated oocytes (Fig. 
41A) exhibited a gene expression pattern very similar to that of control samples (Fig. 
41B). Morphologically, in vitro-generated oocytes (Figs. 41A and 42A) and in vitro-
matured oocytes generated from 18.5 days postcoitum (dpc) germ cells under the 
same culture conditions (Fig. 42C) exhibited a very similar shape, size, and 
microvillous cell surface (Fig. 42C, D). Interestingly, the surface topography of some 
in vitro-derived oocytes analyzed by SEM resembled exactly that of unfertilized 
oocytes in vivo, with the typical sparse and relatively uniform microvillous area and a 
clear mosaic surface containing a polar microvillous-free region (Fig. 42B–D). TEM 
analyses of generated oocytes revealed large, slightly eccentric nuclei with a 
characteristic pale background nucleoplasm (paler than the ooplasm) (Fig. 42E). Free 
ribosomes appeared individually or arranged in clusters of 5–10 (Fig. 42E, insert).  
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Figure 41 Gene expression of oocyte markers in a pool of 3 in vitro-derived oocytes. (from Psathaki et 
al. 2011) (A) Light microscopy image of one of the analyzed oocytes. (B) Real-time reverse 
transcription polymerase chain reaction of oocyte markers in a pool of 3 ESC-derived oocytes 
compared with XX-ESCs. 
 
 
Elongated staples of fibrils not associated with ribosomes were found throughout the 
cytoplasm (Fig. 42E, insert, F). Oocyte-specific cortical granules containing a 
characteristic electron-dense center and a pale outer ring (Fig. 42F, arrow) were 
mostly distributed throughout the cytoplasm and appeared only sporadically at the cell 
periphery (Fig. 42F and inserts), a distinct feature of immature oocytes. Further, we 
detected round as well as elongated mitochondria with a dense matrix and pale, 
irregularly arranged cristae and intermitochondrial vacuoles, all features of natural 
oocytes. Noteworthy is that the majority of ESC-derived oocytes showed signs of 
apoptosis and autophagy, which might be indicative of atresia (Fig. 42E, H). The 
oocyte shown in Fig. 42E lost its spherical shape. Numerous lysosomes, clear vesicles, 
and autophagosomes as well as dark cytoplasmic structures were detected. The ESC-
derived oocyte shown in Fig. 42H contains numerous apoptotic bodies and secondary 
lysosomes within the dark condensed cytoplasm. Mitochondria and other organelles 
cannot be identified. The zona pellucida and most of the microvilli at the oocyte 
surface appear to have been lost. In comparison, oocytes derived from natural 18.5-
dpc PGCs grown for 13 days in the same culture medium as in vitro-derived oocytes 
(Fig. 42G) also exhibit dark-stained mitochondria without cristae, numerous vacuoles, 
and secondary lysosomes; other organelles cannot be identified. Microvilli either have 
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been lost or have retracted from the zona pellucida. These observations indicate that 
our culture conditions support the maturation of PGCs into oogonia, but further 
optimization of these conditions is required for the generation of functional oocytes. 
 
 
 
Figure 42 (continued) 
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Figure 42 Ultrastructural analysis of in vitro-derived oocytes. (from Psathaki et al. 2011) (A) Light 
microscopy image of an in vitro-derived oocyte. (B) SEM image of an in vitro-derived oocyte with a 
polar microvillous-free surface (asterisk). (C) SEM image of fetal in vivo oocytes cultivated under the 
same culture conditions as the in vitro- derived oocytes. Note the polar microvillous-free region 
(asterisk). (D) SEM image of an in vitro-derived oocyte with a polar microvillous-free surface 
(asterisk). Note the similarity of the shape and surface structure to in vivo oocytes shown in C. (E) 
TEM image showing an overview of an in vitro-derived oocyte. Numerous lysosomes, clear vesicles, 
lipid droplets (arrow), and autophagosomes (arrowhead) are distributed throughout the cytoplasm. n: 
nucleus. Insert: Elongated mitochondria with tubular–vesicular cristae and vacuoles are arranged 
between staples of fibrils. (F) TEM image of oocyte-specific cortical granules (arrow) with the typical 
electron-dense center and pale outer ring of in vitro-derived oocytes. Cortical granules appear only 
sporadically in the cell periphery (inserts). Note vacuolated mitochondria (arrowhead). (G) TEM image 
of oocytes derived from natural 18.5 dpc primordial germ cells grown for 13 days in the same culture 
medium as in vitro-derived oocytes. The dark-stained mitochondria contain only few cristae, numerous 
vacuoles, autophagosomes (arrowhead), and secondary lysosomes. Other organelles are not identifiable. 
Microvilli are lost or retracted from the zona pellucida (arrow). (H) TEM image of in vitro-derived 
oocyte showing numerous apoptotic bodies (arrow) and secondary lysosomes in the dark, condensed 
cytoplasm. Mitochondria or other organelles are not identifiable. The zona pellucida and most of the 
microvilli at the oocyte surface are lost. 
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4. Discussion 
4.1. PGC differentiation from human ESCs and iPSCs 
Our laboratory had developed the serum-free defined PGC differentiation protocol for 
mouse ESCs (Psathaki et al, 2011). I initially utilized this protocol to differentiate 
human ESCs. However, this approach was insufficient to induce a SSEA1+/c-KIT+ 
PGC population. It is known that mouse and human ESCs possess distinct 
characteristics, although both cell types are derived from the ICM of blastocysts. For 
example, mouse ESCs require LIF/STAT3 signaling for self-renewal (Niwa et al, 
2009). Furthermore, activation of WNT/#-catenin signaling and inhibition of 
FGF/ERK signaling stabilize their undifferentiated state (Kunath et al, 2007; Sato et 
al, 2004). In contrast, hESCs do not respond to LIF (Dahéron et al, 2004), but depend 
on FGF and TGF# signaling (Amit et al, 2004; Frank et al, 2012; James et al, 2005). 
In addition, WNT/ #-catenin signaling appeares to induce differentiation under 
chemically defined conditions (Sumi et al, 2008). Those facts strongly indicate a 
significant difference between cells of both species and highlight the requirement of 
different approaches to differentiate these cells into germ cells. Interestingly, EpiSCs, 
which are stem cells derived from mouse post-implantation embryos, share some 
properties with human ESCs, such as the flat morphology and FGF-dependent 
maintenance conditions. However, in contrast to mouse EpiSCs, which contain a 
subpopulation of Blimp1+ and Stella+ cells, our investigations indicate that human 
ESCs do not contain subpopulations of BLIMP1+ nor STELLA+ cells. Thus, human 
ESCs possess a distinct character from mouse EpiSCS with respect to the expression 
of PGC genes. Taken together, these data indicate that human ESCs possess different 
characteristics from both mouse ESCs and EpiSCs. 
 
The lack of specific markers for early human PGCs hampers the investigation of 
human PGC commitment processes in vitro. Three studies have reported the 
generation of human GFP reporter ESC and/or iPSCs lines for germ cell 
investigations (Chuang et al, 2012; Kee et al, 2009; Tilgner et al, 2010). Kee et al. and 
Tilgner et al. utilized a VASA-GFP reporter and successfully isolated PGC-like cells 
in vitro (Kee et al.: 5% and Tilgner et al.: 0.8%). However, VASA is expressed in 
PGCs upon colonization of the gonads and is not expressed in PGCs of earlier stages 
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of development. Chuang et al. utilized a OCT4-GFP reporter. OCT4 is known to be 
expressed in early PGCs in mice (Schöler et al, 1990; Yeom et al, 1996) and humans 
(Gaskell et al, 2004; Rajpert-De Meyts et al, 2004), but also in mouse and human 
ESCs (Thomson et al, 1998). Thus, VASA and OCT4 are not really specific markers of 
early PGCs in humans. One of the known earliest genes expressed in human PGCs is 
BLIMP1 (Gkountela et al, 2013; Lin et al, 2014), although BLIMP1 is also known to 
be expressed in other somatic cell types, such as B cells (Turner et al, 1994), 
differentiating macrophages (Chang et al, 2000) and a subset of T-cells (Kallies et al, 
2006; Martins et al, 2006), which do not express OCT4. Therefore, only when OCT4 
and BLIMP1 are co-expressed, the two genes can be considered specific markers of 
early PGCs. Through my analysis, I found that STELLA and TEX13B exhibit 
concomitant upregulation with OCT4 and BLIMP1. TEX13B (mouse homologue: 
Tex13) has been reported to be expressed in testis, but not in ovary, in both mice and 
humans (Wang et al, 2001). However, the expression pattern of TEX13B/Tex13 in 
early PGCs has not yet been investigated. Therefore, it would be of interest, whether 
TEX13B/Tex13 is also expressed in pre-migratory PGCs. Stella is one of the definitive 
markers of early PGCs in mice. Stella knockout mice exhibit no gross PGC defects 
and are fertile (Payer et al, 2003), although Stella seems to play a role in the 
protection of maternal imprints in the zygote (Nakamura et al, 2007; Nakamura et al, 
2012). Nevertheless, several studies have utilized Stella to identify PGCs, due to its 
specific expression in this cell type. In human, the expression pattern of STELLA has 
not been determined. One study reported that undifferentiated human ESCs express 
STELLA (Clark et al, 2004). In contrast, I did not detect significant levels of 
STELLA expression in our human ESC lines. Interestingly, one study reported that 
chromatin around the transcriptional start sites of STELLA is not associated with 
inductive H3K4me3, suggesting that STELLA is not actively transcribed in human 
ESCs (Tesar et al, 2007). The expression level of STELLA in human ESCs has to be 
further investigated to convincingly characterize this particular similarity or 
difference between human ESCs and PGCs. 
 
The establishment of a reproducible and efficient differentiation protocol of human 
PGCs potentially provides the scientific community with an alternative approach to 
investigate germ cell development. All of the published studies on in vitro 
differentiation of human PGCs utilized serum-based medium. Commercial serum 
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bears a huge variation between batches, which are uncontrollable and thus, will result 
in poor reproducibility of available protocols. In fact, my attemps to reproduce the 
protocol by Kee et al. (Kee et al, 2009) resulted in failure to efficiently induce 
SSEA1+/c-KIT+ PGCs from human ESCs, although I used serum from the same 
company. Therefore, in this project, I established a serum-free defined differentiation 
protocol for the induction of PGCs from human ESCs and iPSCs. This protocol 
reproducibly induced OCT4+/T+/BLIMP1+ PGC precursors that transitioned into 
TRA-1-81+/c-KIT+ pre-migratory PGC-like cells. In this system, not all cells were 
similar to PGCs, likely due to some stochastic/physical parameters or intrinsic 
differences. However, considering the fact that PGC induction directly from 
ESCs/iPSCs so far gave rise to only low numbers of PGC-like cells, it becomes 
apparent, that the two-step induction procedure developed in my thesis strongly 
induced PGC precursors and subsequently PGC-like cells. To my knowledge, this is 
the first report of a serum-free defined differentiation protocol for the induction of 
human PGCs in vitro. 
 
My data suggest that Activin A, BMP4, and bFGF are important for the induction of 
OCT4+/T+/BLIMP1+ PGC precursors from human ESCs and iPSCs, and point to two 
different possibilities. The first possibility is that human PGC specification, in 
contrast to mouse PGC specification, requires the activation of TGFβ signaling. 
Mouse ex vivo PGC induction from epiblast has been shown to require BMP4 and 
bFGF, whereas the knock-out of Smad2, a transducer of TGFpiblast has been shown 
to require BMP4 and bFGF, whereas the knock-out of  PGC precursors fr(Ohinata et 
al, 2009). These results indicate that BMP and FGF signaling enhance PGC 
specification, whereas TGFt of  PGC precursors from human ESCs and iPSCs, and 
point to two different poss disc-like shape that is physically closer to the distal 
hypoblast in comparison to the cylinder-like shape of the mouse epiblast (Niakan et al, 
2012). Therefore, it is possible that the human epiblast and PGCs exhibit different 
reactivity to TGFβ signaling than their mouse counterparts. The second possibility is 
that even though human ESCs and mouse EpiSCs share many features, such as 
morphology and gene expression profiles, the state of human ESCs might be closer to 
the naïve cell state than to a primed state with regard to their PGC differentiation 
ability. In mice, BMP4 treatment of EpiSCs in vitro induces Blimp1+ cells, but most 
?";,+;;")&!
! 53!
of these cells do not progress to become Stella+ PGC-like cells (Hayashi et al, 2011; 
Hayashi & Surani, 2009). Interestingly, when EpiSCs were reverted to ESC-like cells, 
they gained the ability to differentiate into Blimp1+/Stella+ PGC-like cells (Hayashi 
et al, 2011). These data suggest that EpiSCs exhibit restricted PGC differentiation 
ability compared with ESCs. Indeed, a previous study showed the divergence of 
EpiSCs from ESCs as well as epiblast by global transcription analysis (Hayashi et al, 
2011). In this context, my data clearly show that human ESCs and iPSCs generate 
OCT4+/T+/BLIMP1+ PGC precursors that transition under appropriate culture 
conditions into PGC-like cells with key PGC gene expression, i.e., BLIMP1, STELLA, 
TFAP2C, and NANOS3. 
 
BMP4 played a critical role in the induction of PGC-like cells and enhanced induction 
in a concentration-dependent manner in our culture system, similar to serum-based 
differentiation culture systems (Kee et al, 2006). Apart from BMP proteins, SCF, 
EGF, and bFGF have also been reported to enhance PGC induction in mice (Ohinata 
et al, 2009). In particular, SCF (also known as KITLG) is considered to be necessary 
for PGC survival (Pesce et al, 1993). As we observed the rapid disappearance of the 
TRA-1-81+/c-KIT+ PGC-like cell population within 2 days of culture, we attempted 
to extend the proliferation of PGC-like cells by SCF, but this approach proved to be 
insufficient. On the other hand, according to the GSEA analysis, genes related to lipid, 
hormone, and steroid metabolic processes were upregulated in d6 PGC-like cells 
(Supplementary Table 3). Therefore, the addition of hormones to the culture might be 
an alternative approach for extending and rescuing the development of human PGC-
like cells in vitro. For example, retinoic acid (RA) is known to be associated with the 
initiation of meiosis during PGC development and follicle stimulating hormone (FSH) 
and luteinizing hormone (LH) are known to play an important role in oogenesis. 
However, an involvement of hormonesin PGC survival or proliferation has not been 
reported. Whether hormonal treatment of human PGC-like cells enhances 
proliferation warrants further investigations. 
 
The human PGC-like cells exhibited expression of OCT4, NANOG, BLIMP1, and 
STELLA, which is characteristic for mouse pre-migratory PGCs. I also confirmed by 
gene expression array analysis that human in vivo post-migratory female PGCs 
express high levels of BLIMP1 and STELLA, similarly to the human PGC-like cells 
?";,+;;")&!
!54!
and mouse PGCs, suggesting that characteristics of PGCs are conserved between 
these two species. In addition, global transcription analysis revealed that during 
differentiation, mesodermal genes, such as MESP1, CYP26A1, MIXL1, and GSC, 
were initially upregulated and subsequently downregulated. Concomitantly, PGC 
genes, such as BLIMP1, TFAP2C, STELLA, and NANOS3, were upregulated. This is 
similar to the gene expression dynamics observed during mouse PGC specification 
and indicates that the gene expression dynamics of some gene sets during PGC 
specification are conserved between humans and mice. In contrast, these cells showed 
very low expression levels of SOX2 and PRDM14, which seems to be a unique 
characteristics of human PGCs. 
 
In mice Blimp1 is one of the earliest genes expressed in mouse PGCs and its 
expression is first detected in approximately six cells in the posterior epiblast at 6.25 
dpc (Ohinata et al, 2005). Knock-out of Blimp1 leads to the failure of Hoxa1 or 
Hoxb1 expressionm and loss of PGCs by 7.5 dpc (Kurimoto et al, 2008; Ohinata et al, 
2005). Therefore, it is assumed that Blimp1 plays a key role in repression of the 
somatic program during PGC specification. Interestingly, a number of specification-
associated genes are still induced, although relatively weak, in the absence of Blimp1, 
suggesting that there are Blimp1-independent mechanisms during specification 
(Kurimoto et al, 2008). In humans, BLIMP1 is reported to be expressed in human 
PGCs/gonocytes at around 12 to 19 week of pregnancy (Eckert et al, 2008). However, 
the expression pattern of BLIMP1 in earlier stages has not been reported. Interestingly, 
I observed that a subset of mesodermal genes, such as MESP1, CYP26A1, MIXL1, and 
GSC, was initially upregulated in PGC-precursor cultures and subsequently 
downregulated in BLIMP1-expressing PGC-like cells. This gene dynamics might 
depict the indication that BLIMP1 plays an important role during human PGC 
specification by suppressing those mesodermal genes. In fact, I showed that the 
knock-down of BLIMP1 impairs the induction of TRA-1-81+/c-KIT+ PGC-like cells, 
which has also been reported by another study (Lin et al, 2014). Further investigation 
need to clarify how BLIMP1 functions during human PGC specification. 
 
The re-acquisition of Sox2 expression is one of the characteristics of PGC 
specification in mice (Kurimoto et al, 2008; Yabuta et al, 2006). Sox2 is repressed at 
the initiation of specification (6.25 dpc) and re-acquired upon establishment of 
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committed PGCs (7.25-7.5 dpc), while Oct4 and Nanog are constantly expressed. 
Sox3 and Sox17 also are transiently and specifically upregulated in PGCs at around 
7.25 dpc. In contrast, human PGCs appear to lack the expression of SOX2 (de Jong et 
al, 2008; Perrett et al, 2008). The expression of SOX3 and SOX17 in human PGCs has 
not been examined yet, but it has been reported that SOX17 is expressed in carcinoma 
in situ (CIS) and seminoma cells, but not in embryonic carcinoma (EC) cells (de Jong 
et al, 2008). The PGC-like cells exhibited a low SOX2 expression level in accordance 
with the mentioned studies. Interestingly, SOX17 is upregulated in PGC-like cells, 
whereas SOX3 is not upregulated, but rather downregulated (data not shown). How 
those SOX genes are regulated during human PGC commitment and how much the 
expression of SOX genes is conserved between mice will require further investigation. 
 
Surprisingly, only low PRDM14 expression levels could be detected in PGC-like cells. 
In mice, Prdm14 plays a key role in ESCs and PGCs. In ESCs, Prdm14 has been 
reported to repress extraembryonic endoderm (ExEn) differentiation in ESCs (Ma et 
al, 2011). Furthermore, a recent study revealed that Prdm14 antagonizes activation of 
the fibroblast growth factor receptor (FGFR) signaling and represses expression of de 
novo DNA methyltransferases (Dnmts) to ensure naïve pluripotency (Yamaji et al, 
2013). Prdm14 has also been identified as a critical regulator for PGC specification 
from the epiblast (Yamaji et al, 2008). Prdm14 knock- out mice are sterile and show a 
progressive loss of PGCs between 7.5 and 12.5 dpc, although a few AP-positive cells 
do remain even at the latter time point (Yamaji et al., 2008). Somatic genes are 
appropriately repressed, suggesting that Prdm14 does not function to repress the 
somatic program but is required for activation of the PGC program. In fact, a recent 
mouse study showed that ectopic expression of Prdm14 alone can induce PGC-like 
cells from Epiblast-like cell (EpiLCs) without activating the somatic program. The 
authors also suggested that Prdm14 plays a key role in the repression of neural 
induction and de novo methylation, as well as in the activation of the PGC program 
during specification (Nakaki et al, 2013). In humans, PRDM14 plays a crucial role in 
the maintenance of human pluripotency by binding to OCT4 regulatory elements and 
thereby regulating OCT4 expression and by suppressing the differentiation of human 
ESCs (Chia et al, 2010). PRDM14 is also thought to repress the expression of PGC-
associated genes, such as NANOS3 and BMP4, in human ESCs. On the other hand, 
the expression pattern of PRDM14 in human PGCs has not been studied. My data, for 
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the first time, demonstrate low or even absent expression of PRDM14 in PGCs. I 
confirmed that post-migratory in vivo human PGCs also exhibit a very low expression 
level of PRDM14, whereas mouse PGCLCs exhibit a high expression level of this 
gene. These results suggest that human PGCs do not express PRDM14 from their 
early commitment to the germ cell lineage through at least the post-migratory stage. 
In fact, I demonstrated that the knock-down of PRDM14 did not affect the induction 
of TRA-1-81+/c-KIT+ PGC-like cells, whereas that of BLIMP1 significantly impaired 
it. My data revealed that human PGC-like cells show some mouse Prdm14-regulated 
events, such as: 1) the downregulation of genes associated with neural differentiation, 
2) similar expression dynamics of a number of mouse Prdm14-regulated genes (such 
as KLF5, NR5A2, KLF4, LIFR, and NANOG), 3) the progression of global epigenetic 
reprogramming by demethylation of differentially methylated regions (DMRs) of 
selective imprinted genes and a global decrease in 5mC levels, and 4) the expression 
of OCT4, NANOG, and other pluripotency genes. The mechanism underlying the 
regulation of these genes is undetermined at this time. However, my data strongly 
suggest the presence of yet unknown mechanisms underlying a novel type of 
transcriptional regulation in humans. PGCs from Prdm14-deficient mice have been 
reported to exhibit abnormal expression of Sox2, indicating a putative interaction 
between Prdm14 and Sox2 in mice (Yamaji et al, 2008). Considering that Prdm14 
plays a crucial function in the re-acquisition of Sox2 expression in mouse PGCs, it 
might be reasonable to postulate that SOX2 is not expressed in human PGCs due to 
the absence of PRDM14. On the other hand, a recent human study demonstrated that 
BLIMP1 binds to a region around the SOX2 transcriptional start site suppressing 
SOX2 expression (Lin et al, 2014). However, the downregulation of SOX2 is a general 
phenomenon of BMP4-triggered mesoderm commitment, independent from the 
expression of BLIMP1. In fact, we also observed the downregulation of SOX2 in 
FACS-sorted c-KIT- somatic populations from our differentiated EBs. Thus, the 
suppression of SOX2 by BLIMP1 might be a feedback mechanism to maintain the 
cell state. Whether human PGCs utilize another mechanisms to actively or passively 
downregulate SOX2 warrants further investigations. 
 
Taken together, my differentiation protocol facilitates the generation of sufficient 
amounts of PGC-like cells to investigate gene/protein interactions and epigenetic 
alterations. Through this study, I provide insight into a novel human transcriptional 
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regulation during the early stage of human PGC development (3–6 weeks). Continued 
investigations will provide us with a more comprehensive understanding of human 
germ cell development and the opportunity to perform research for reproductive 
medicine, such as drug screening and disease modeling, by utilizing patient-specific 
iPSCs from reproductively compromised patients.  
 
4.2. PGC differentiation from mouse EpiSCs and ΔPE-Oct4-GFP+ EpiSCs 
There have been two reports on the induction of PGCs from mouse EpiSCs (Hayashi 
et al, 2011; Hayashi & Surani, 2009). Interestingly, both studies demonstrated 
inefficient or no induction of PGCs from EpiSCs. The first study (Hayashi & Surani, 
2009) reported that EpiSCs contain a subpopulation of Blimp1+ cells (10-50 %), 
some of which were also OCT4+, indicating a spontaneous generation of the PGC 
precursors and visceral endoderm (VE) cells.. The authors demonstrated that BMP4 
treatment slightly induced Stella+ cells, but they did not achieve a significant 
induction, considering the percentage of Blimp1+ cells within EpiSCs. This indicates 
that Blimp1+ cells retain their PGC precursor-like state, even after induction with 
BMP4. The second study (Hayashi et al, 2011) reported the efficient induction of 
PGC-like cells from ESCs via an epiblast-like state. The differentiation regimen used 
contained BMP4 and induced PGC-like cells (Blimp1+/Stella+) from the epiblast and 
from EpiLCs. However, EpiSCs produced only Blimp1+ cell that did not develop into 
Blimp+/Stella+ PGC-like cells. Interestingly, our differentiation system induced 
Oct4+GFP+/SSEA1+, but not c-KIT+ cells from EpiSCs. SSEA1 is not expressed in 
mouse EpiSCs, but is expressed in mouse ESCs and PGCs. Thus, the expression of 
SSEA1 might indicate the transition of cells from EpiSCs to PGCs, similar to the 
previous studies. Further optimization of the culture conditions might stimulate these 
cells to develop into Oct4+GFP+/c-KIT+ putative PGCs. 
 
In this study, we succeeded to induce putative PGCs from mouse EpiSCs only once 
and failed to reproduce it. Several points can be considered as a potential cause. For 
example, we used MEF-conditioned medium (MEF-CM) for the maintenance and 
differentiation of EpiSCs. MEF preparations greatly vary in terms of quality and 
biological character, such as sensitivity to cytokines. MEF-CM therefore also exhibits 
batch-dependent differences, like varying concentrations of secreted components like 
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for instance Activin A. Interestingly, it has been reported that the knock-out of Smad2, 
a transducer of TGFβ signaling, leads to an increased number of Blimp1+ PGCs in 
the epiblast (Ohinata et al, 2009). In addition, it is known that EpiSCs contain a 
subpopulation of PGC precursors and the number of cells is strongly influenced by 
the medium composition. Thus, the concentration of Activin A in MEF-CM could 
significantly affect the differentiation efficiency of PGCs from EpiSCs. Those facts 
strongly suggest the use of defined medium for PGC differentiation from mouse 
EpiSCs.  
 
We also attempted PGC differentiation from so called stabilized EpiSCs (Δso called 
st). Similar to the induction from normal EpiSCs, we could not induce Oct4-GFP+/c-
KIT+ putative PGCs, but obtained Oct4-GFP+/SSEA1+ cells. Interestingly, SSEA1+ 
as well as SSEA1- cells, i.e. the whole culture upregulated a number of PGC genes, 
such as Blimp1, Prdm14, Stella and Dazl. Contrary to our expectation that s, such as 
Blimp1, Prdm14, Stella and Dazl.  Activin A in MEF-CM coulsimilar gene 
expression profile to E5.5 epiblast, we did not observe any difference between normal 
EpiSCs and ΔPE-Oct4-GFP+ EpiSCs. Again, the utilization of a defined PGC 
differentiation protocol for mouse EpiSCs is required to investigate the differentiation 
potential of the two EpiSC lines. 
 
4.3. Ultrastructural characterization of mouse embryonic stem cell-derived 
oocytes and granulosa cells 
The first systematic study of the culture and growth of mouse oocytes in vitro was 
published by the laboratory of John Eppig (Eppig, 1977). As shown in that study 
mouse oocytes from primordial follicles could be grown and matured in vitro to 
produce live offspring after fertilization (Eppig & Schroeder, 1989; O'Brien et al, 
2003). These data marked a major breakthrough in the field of reproductive biology. 
Based on this success, various in vitro culture systems for female gametes of different 
mammalian species were established, such as rat (Daniel et al, 1989), hamster (Roy & 
Greenwald, 1989), cat (Jewgenow, 1998), pig (Hirao et al, 1994), sheep (Cecconi et 
al, 1999), goat (Huanmin & Yong, 2000), cow (Gutierrez et al, 2000; Harada et al, 
1997), and human (Roy & Treacy, 1993). All these maturation systems, including the 
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mouse model, are still under investigation in an effort to broaden our understanding of 
the complex mechanisms involved in germ cell development and maturation. In our 
study, we performed comparative ultrastructural analyses of follicle-like structures 
and bona fide oocytes from mouse ESCs with their natural counterparts. With our 
data, we supplement the genetic and immunological data obtained by standard 
analyses with a description of the unique ultrastructural properties of oocytes and 
their supporting granulosa cells during gametogenesis in vivo. Specifically, we 
performed SEM analysis on in vitro-derived follicle-like structures and compared 
their morphology with that of natural mammalian follicles described by Makabe et al. 
in 2006 (Makabe et al, 2006). Striking morphological similarities indicate that our 
culture system supports the derivation of germ cells of different developmental 
follicular stages. We utilized TEM analysis to assess differences in the dynamic 
structure of TZPs, which form the morphological basis of the oocyte–granulosa cell 
interface and play a crucial role in the structural integrity of developing follicles and 
maturing oocytes (Albertini et al, 2001). Many of our in vitro-derived granulosa cells 
developed microvilli, cytoplasmic invaginations, pseudopodia, and cytoplasmic 
protrusions (not shown here), which have been associated with cell expansion and are 
considered indirect signs of granulosa cell luteinization both in vitro and in vivo 
(Suzuki et al, 1981). The presence of numerous lipid droplets within the cytoplasm of 
in vitro-derived granulosa cells, an early sign of luteinization (Crisp et al, 1970), 
correlates with active steroidogenesis (Nottola et al, 2006). Taken together, in vitro-
derived granulosa cells exhibit ultrastructural characteristics typical for metabolically 
active and steroid-producing cells. 
 
The ovarian follicle represents a morphological and functional unit wherein both 
somatic and germ cells play a pivotal role in follicle maturation and formation of fully 
competent, fertilizable oocytes (Canipari, 2000). SEM analysis clearly demonstrated 
that ESC-derived cuboidal-shaped granulosa cells closely surround the oocyte and 
extend long TZPs toward the oocyte. In vivo, TZPs are most abundant in preantral 
follicles. By TEM analysis, we demonstrated that ESC-derived cumulus cells extend 
typical TZPs, some of which contain mitochondria, an observation consistent with the 
literature (Albertini et al, 2001; Zamboni, 1970). TZPs are an essential requirement 
for healthy follicle development (Albertini et al, 2001) and the ultrastructure of TZPs 
of our in vitro-derived granulosa cells demonstrates a profound conformity to that of 
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natural granulosa cells. This data demonstrate the establishment of an interface, that is, 
the major control site between the oocyte and granulosa cells in vitro. The 
ultrastructure of the ECM matrix of the in vivo cumulus–oocyte complex closely 
resembles that of the matrix penetrated by the TZPs of the in vitro-derived granulosa 
cells. 
 
Comparative morphological analysis of ESC-derived oocytes and in vivo oocytes 
revealed remarkable similarities. The oocyte surface varies greatly from one stage of 
the cell cycle to the other and even within a given stage, suggesting a close 
association between the surface characteristics and the maturation status of the oocyte 
(Suzuki et al, 2000). A mature, unfertilized mouse oocyte is characterized by small 
blebs and sparse, relatively uniform microvilli (Eager et al, 1976; Suzuki et al, 2000) 
as well as a clear mosaic surface, that is, a microvillous membrane with a smooth, 
microvillous-free polar region. This region is relatively free of organelles (Eager et al, 
1976) and has fewer granules (Ducibella et al, 1988). SEM analysis of in vitro-
derived oocytes from late cultures revealed a mosaic surface topography typical for 
mature unfertilized oocytes. 
 
The formation of cortical granules begins during oocyte maturation (Zamboni, 1970) 
and the distribution of cortical granules in the mouse oocyte cortex changes 
dynamically during meiotic maturation (Ducibella et al, 1988). Cortical granules are 
round or elliptical in shape, measure 0.2–0.5 mm in diameter, and consist of a highly 
dense matrix surrounded by a single smooth membrane (Zamboni, 1970). As 
described by Ducibella et al. (Ducibella et al, 1988), in immature oocytes, cortical 
granules are distributed asymmetrically throughout the cortex, whereas in mature 
oocytes, they are localized mainly to the cortex periphery and are fewer in number. 
TEM analysis of ESC-derived oocytes showed numerous cortical granules distributed 
over the entire cortex, with only a few granules at the oocyte periphery, which is 
indicative for immature oocytes. The distribution of cortical granules and their 
competence to undergo cortical reaction are important indicators of oocyte 
cytoplasmic maturation and provide valuable information about the fertilizable 
lifespan of the oocyte (Ducibella et al, 1988). Overall, these ultrastructural data 
suggest that the analyzed ESC-derived oocytes resembled immature and growing 
wild-type oocytes.  
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Although the derivation and culture of female germ cells from pluripotent stem cells 
in vitro may lead to ultrastructural alterations in oocytes, this study demonstrates that 
an in vitro culture system can create the essential components required for oocyte 
development: oocytes, an ECM-based interface, and granulosa-like cells. Future 
efforts to optimize in vitro differentiation conditions should bring us closer to our 
ultimate goal of generating fully functional oocytes and demonstrate whether all key 
events of germ cell development in vivo can be truthfully recapitulated in vitro. 
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